OMIM ID Disease name
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT
100070 AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1
100100 ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM
100200 ABDUCENS PALSY
100300 ADAMS-OLIVER SYNDROME 1; AOS1
100600 ACANTHOSIS NIGRICANS
100675 ACETAMINOPHEN METABOLISM
100700 ACHARD SYNDROME
100800 ACHONDROPLASIA; ACH
101000 NEUROFIBROMATOSIS, TYPE II; NF2
101120 ACROCEPHALOPOLYSYNDACTYLY TYPE III
101200 APERT SYNDROME
101400 SAETHRE-CHOTZEN SYNDROME; SCS
101600 PFEIFFER SYNDROME
101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1
101840 ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT
101850 KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE III; PPKP3
101900 ACROKERATOSIS VERRUCIFORMIS; AKV
102000 ACROLEUKOPATHY, SYMMETRIC
102100 ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA
102150 ACROMEGALOID FACIAL APPEARANCE SYNDROME
102200 PITUITARY ADENOMA, GROWTH HORMONE-SECRETING
102300 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1
102350 ACROMIAL DIMPLES
102370 ACROMICRIC DYSPLASIA; ACMICD
102400 ACROOSTEOLYSIS
102500 HAJDU-CHENEY SYNDROME; HJCYS
102510 ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV
102520 ACRORENAL SYNDROME
102530 SPERMATOGENIC FAILURE 6; SPGF6
102650 ADACTYLIA, UNILATERAL
102660 ADAMANTINOMA OF LONG BONES
102700 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
102730 ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO
102800 ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO
102900 ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES
103050 ADENYLOSUCCINASE DEFICIENCY
103100 ADIE PUPIL
103200 ADIPOSIS DOLOROSA
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL
103285 ADULT SYNDROME
103300 HYPOGLOSSIA-HYPODACTYLIA
103400 AINHUM
103420 ALACRIMA, CONGENITAL
103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS
103500 TIETZ SYNDROME
103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A
103900 GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA
103920 ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL
104000 ALOPECIA AREATA 1
104100 PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL DOMINANT
104110 ALOPECIA, FAMILIAL FOCAL
104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY
104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT
104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD
104300 ALZHEIMER DISEASE; AD
104310 ALZHEIMER DISEASE 2
104350 AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM
104400 AMELIA AND TERMINAL TRANSVERSE HEMIMELIA
104500 AMELOGENESIS IMPERFECTA, TYPE IB; AI1B
104510 AMELOGENESIS IMPERFECTA, TYPE IV; AI4
104530 AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE MICRODONTIA, GENERALIZED, INCLUDED
104570 AMELOONYCHOHYPOHIDROTIC SYNDROME
104600 AMENORRHEA-GALACTORRHEA SYNDROME
105120 AMYLOIDOSIS, FINNISH TYPE
105150 CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED
105200 AMYLOIDOSIS, FAMILIAL VISCERAL
105210 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
105250 AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1
105300 AMYOTROPHIC DYSTONIC PARAPLEGIA
105400 AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
105500 AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1
105550 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS
105563 ANAL SPHINCTER DYSPLASIA; ASDP
105565 ANAL SPHINCTER MYOPATHY, INTERNAL
105580 ANAL CANAL CARCINOMA CLOACOGENIC CARCINOMA, INCLUDED
105600 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III; CDAN3
105650 DIAMOND-BLACKFAN ANEMIA; DBA
105800 ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1
105805 ANEURYSM OF INTERVENTRICULAR SEPTUM
105830 ANGELMAN SYNDROME; AS
105835 ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED
106050 ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT
106070 ANGIOMA, HEREDITARY NEUROCUTANEOUS SPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED
106100 ANGIOEDEMA, HEREDITARY, TYPE I; HAE1
106190 ANHIDROSIS, FAMILIAL GENERALIZED, WITH NORMAL SWEAT GLANDS
106210 ANIRIDIA; AN
106220 ANIRIDIA AND ABSENT PATELLA
106230 ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT
106240 ANISOCORIA
106250 ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA
106260 ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE
106280 ANKYLOGLOSSIA
106300 SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
106400 ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS, INCLUDED; DISH, INCLUDED
106500 ANNULAR ERYTHEMA
106600 TOOTH AGENESIS, SELECTIVE, 1; STHAG1
106700 TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
106750 ANONYCHIA WITH FLEXURAL PIGMENTATION
106900 ANONYCHIA-ECTRODACTYLY
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY
106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES
107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6
107100 ANORECTAL ANOMALIES
107200 ANOSMIA, ISOLATED CONGENITAL; ANIC
107250 ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD
107320 ANTIPHOSPHOLIPID SYNDROME, FAMILIAL
107480 TOWNES-BROCKS SYNDROME; TBS
107500 AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA
107600 APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC
107640 APNEA, CENTRAL SLEEP
107650 APNEA, OBSTRUCTIVE SLEEP
107700 APPENDICITIS, PRONENESS TO
107900 ARMS, MALFORMATION OF
107970 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
108000 ARTERIES, ANOMALIES OF
108010 ARTERIOVENOUS MALFORMATIONS OF THE BRAIN
108050 ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS
108100 ARTHRITIS, SACROILIAC
108110 ARTHROGRYPOSIS MULTIPLEX CONGENITA; AMC
108120 ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A
108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5
108200 ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6
108300 STICKLER SYNDROME, TYPE I; STL1
108320 ARTICHOKE, MODIFICATION OF TASTE BY
108450 ASYMMETRIC SHORT STATURE SYNDROME
108500 EPISODIC ATAXIA, TYPE 2; EA2
108600 SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1
108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7
108700 ATAXIA WITH FASCICULATIONS
108720 ATELOSTEOGENESIS, TYPE I; AOI
108721 ATELOSTEOGENESIS, TYPE III; AOIII
108725 ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS
108760 ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS
108770 ATRIAL STANDSTILL
108800 ATRIAL SEPTAL DEFECT 1; ASD1 ATRIAL SEPTAL DEFECT, PRIMUM TYPE, INCLUDED
108900 ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7
108950 ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL
108985 SVEINSSON CHORIORETINAL ATROPHY; SCRA
109000 AURICULOOSTEODYSPLASIA
109050 AUROCEPHALOSYNDACTYLY
109100 AUTOIMMUNE DISEASE
109120 AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES
109130 AXIAL OSTEOMALACIA
109150 MACHADO-JOSEPH DISEASE; MJD
109160 AZOTEMIA, FAMILIAL
109200 ALOPECIA, ANDROGENETIC, 1; AGA1
109300 BANKI SYNDROME
109350 GASTROESOPHAGEAL REFLUX; GER
109400 BASAL CELL NEVUS SYNDROME; BCNS
109500 BASILAR IMPRESSION, PRIMARY
109543 LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2
109650 BEHCET SYNDROME
109720 BILIARY CIRRHOSIS, PRIMARY, 1; PBC1
109730 AORTIC VALVE DISEASE
109740 BIFID NOSE, AUTOSOMAL DOMINANT
109800 BLADDER CANCER
109820 BLADDER DIVERTICULUM
109900 BLEPHAROCHALASIS AND DOUBLE LIP
110000 BLEPHAROCHALASIS, SUPERIOR
110050 BLEPHARONASOFACIAL MALFORMATION SYNDROME
110100 BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES BPES, TYPE I, INCLUDED
110150 BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS
110700 BLOOD GROUP, DUFFY SYSTEM; FY
112200 BLUE RUBBER BLEB NEVUS
112240 BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES
112250 DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH
112270 BONE PAIN, PERIODIC
112300 BOOK SYNDROME
112310 BOOMERANG DYSPLASIA
112350 BOWING OF LEGS, ANTERIOR, WITH DWARFISM
112370 BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY
112410 HYPERTENSION WITH BRACHYDACTYLY
112430 LONG-THUMB BRACHYDACTYLY SYNDROME
112440 BRACHYDACTYLY, COMBINED B AND E TYPES
112450 BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION
112500 BRACHYDACTYLY, TYPE A1; BDA1
112600 BRACHYDACTYLY, TYPE A2; BDA2
112700 BRACHYDACTYLY, TYPE A3; BDA3
112800 BRACHYDACTYLY, TYPE A4; BDA4
112900 BRACHYDACTYLY, TYPE A5, WITH NAIL DYSPLASIA
112910 BRACHYDACTYLY, TYPE A6; BDA6
113000 BRACHYDACTYLY, TYPE B1; BDB1
113100 BRACHYDACTYLY, TYPE C; BDC
113200 BRACHYDACTYLY, TYPE D; BDD
113300 BRACHYDACTYLY, TYPE E1; BDE1
113301 BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II
113310 BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA
113400 BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME
113470 BRACHYMESOMELIA-RENAL SYNDROME
113475 BRACHYMETATARSUS IV
113477 BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME
113500 BRACHYOLMIA TYPE 3
113600 BRANCHIAL CLEFT ANOMALIES BRANCHIAL CYSTS, INCLUDED
113610 BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA
113620 BRANCHIOOCULOFACIAL SYNDROME; BOFS
113650 BRANCHIOOTORENAL SYNDROME 1; BOR1
113670 HYPERTROPHY OF THE BREAST, JUVENILE; JHB
113700 BREASTS AND NIPPLES, ABSENCE OF
113750 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4; SHEP4
113800 EPIDERMOLYTIC HYPERKERATOSIS; EHK
113900 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A
113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT
113970 BURKITT LYMPHOMA; BL
114000 CAFFEY DISEASE
114030 CAFE-AU-LAIT SPOTS, MULTIPLE
114065 CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL
114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET
114140 CALLOSITIES, HEREDITARY PAINFUL
114150 CAMPTOBRACHYDACTYLY
114200 CAMPTODACTYLY 1; CAMPD1
114290 CAMPOMELIC DYSPLASIA
114300 ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3
114450 CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE
114480 BREAST CANCER
114500 COLORECTAL CANCER; CRC
114550 HEPATOCELLULAR CARCINOMA
114580 CANDIDIASIS, FAMILIAL, 1; CANDF1
114600 CANINE TEETH, ABSENCE OF UPPER PERMANENT
114620 CRANIOFACIOFRONTODIGITAL SYNDROME
114650 CAR FACTOR DEFICIENCY
114700 CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH
114900 CARCINOID TUMORS, INTESTINAL
115000 CARDIAC ARRHYTHMIA
115080 CARDIAC CONDUCTION DEFECT SUDDEN CARDIAC DEATH, INCLUDED; SCD, INCLUDED
115150 CARDIOFACIOCUTANEOUS SYNDROME
115195 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
115196 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3
115197 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4, SUSCEPTIBILITY TO, INCLUDED
115200 CARDIOMYOPATHY, DILATED, 1A; CMD1A
115210 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1
115250 COLLAGENOMA, FAMILIAL CUTANEOUS
115300 HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT CAROTENOIDS, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1, INCLUDED
115310 PARAGANGLIOMAS 4; PGL4
115430 CARPAL TUNNEL SYNDROME; CTS1
115470 CAT EYE SYNDROME; CES
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION
115650 CATARACT, ANTERIOR POLAR, 1; CTAA1
115660 CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1
115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV
115700 CATARACT, CRYSTALLINE ACULEIFORM
115800 CATARACT, CRYSTALLINE CORALLIFORM
115900 CATARACT, FLORIFORM
116100 CATARACT, MEMBRANOUS
116150 CATARACT-MICROCORNEA SYNDROME
116200 CATARACT, ZONULAR PULVERULENT 1; CZP1
116300 CATARACT, NUCLEAR DIFFUSE NONPROGRESSIVE
116400 CATARACT, NUCLEAR TOTAL
116600 CATARACT, POSTERIOR POLAR, 1; CTPP1
116700 CATARACT, TOTAL CONGENITAL; CC
116800 CATARACT, LAMELLAR
116850 CATATRICHY
116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM
116870 CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM
116920 LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD
117000 CENTRAL CORE DISEASE OF MUSCLE
117100 CENTRALOPATHIC EPILEPSY
117210 SPINOCEREBELLAR ATAXIA 31; SCA31
117300 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2
117360 SPINOCEREBELLAR ATAXIA 29; SCA29
117550 SOTOS SYNDROME 1; SOTOS1
117600 CEREBRAL SARCOMA
117650 CEREBROCOSTOMANDIBULAR SYNDROME
117800 APOCRINE GLAND SECRETION, VARIATION IN
117850 CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS
117900 CERVICAL RIB
118000 CERVICAL VERTEBRAL BRIDGE
118005 CERVICAL VERTEBRAL DYSPLASIA
118100 KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1
118200 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1
118220 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE
118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM
118330 CHEILITIS GLANDULARIS
118350 CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS
118400 CHERUBISM
118420 CHIARI MALFORMATION TYPE I
118430 CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF
118450 ALAGILLE SYNDROME 1; ALGS1
118600 CHONDROCALCINOSIS 2; CCAL2
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION
118650 CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT CHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED
118651 CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE
118700 CHOREA, BENIGN HEREDITARY; BHC
118750 CHOREOATHETOSIS, FAMILIAL INVERTED
118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1
118830 CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE
118865 CHOROIDAL OSTEOMA, BILATERAL
118900 CIRRHOSIS, FAMILIAL
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL
119000 CLEFT CHIN
119100 SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1
119300 VAN DER WOUDE SYNDROME 1; VWS1
119500 POPLITEAL PTERYGIUM SYNDROME; PPS
119530 OROFACIAL CLEFT 1; OFC1
119540 CLEFT PALATE, ISOLATED; CPI
119550 SYNGNATHIA
119570 CLEFT SOFT PALATE
119580 BLEPHAROCHEILODONTIC SYNDROME
119600 CLEIDOCRANIAL DYSPLASIA; CCD
119650 CLEIDORHIZOMELIC SYNDROME
119800 CLUBFOOT, CONGENITAL; CCF
119900 DIGITAL CLUBBING, ISOLATED CONGENITAL
119915 CLUSTER HEADACHE, FAMILIAL
120000 COARCTATION OF AORTA
120040 COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS
120100 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1
120200 COLOBOMA, OCULAR
120300 COLOBOMA OF MACULA
120330 PAPILLORENAL SYNDROME
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY
120430 COLOBOMA OF OPTIC NERVE OPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED
120435 LYNCH SYNDROME I
120440 COLONIC VARICES WITHOUT PORTAL HYPERTENSION
120450 COMEDONES, FAMILIAL DYSKERATOTIC
120500 COMMISSURAL LIP PITS
120502 BRANCHIOOTIC SYNDROME 2
120790 COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
120970 CONE-ROD DYSTROPHY 2; CORD2
121050 ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9
121070 ARTHROGRYPOSIS, DISTAL, TYPE 2E
121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1 EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED
121201 SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2
121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1
121270 COPPER DEFICIENCY, FAMILIAL BENIGN
121300 COPROPORPHYRIA, HEREDITARY; HCP
121350 CORACOCLAVICULAR JOINT, ANOMALOUS
121390 CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS
121400 CORNEA PLANA 1; CNA1
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS
121700 CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT; CHED1
121800 CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER
121820 CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD
121850 CORNEAL DYSTROPHY, FLECK
121900 CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1
122000 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1
122100 CORNEAL DYSTROPHY, MEESMANN; MECD
122200 CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1
122400 EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION
122440 CORNEODERMATOOSSEOUS SYNDROME
122450 CORNEAL HYPESTHESIA, FAMILIAL
122455 CORONARY ARTERY DISSECTION, SPONTANEOUS
122460 HUMAN CORONAVIRUS SENSITIVITY; HCVS
122470 CORNELIA DE LANGE SYNDROME 1; CDLS1
122580 COSTOCORACOID LIGAMENT, CONGENITALLY SHORT
122600 SPONDYLOCOSTAL DYSOSTOSIS 5, AUTOSOMAL DOMINANT; SCDO5
122750 COXA VARA
122780 COXOAURICULAR SYNDROME
122850 CRANIOACROFACIAL SYNDROME
122860 CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD
122880 CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS
122900 CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA
123000 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD
123050 CRANIORHINY
123100 CRANIOSYNOSTOSIS, TYPE 1; CRS1
123150 JACKSON-WEISS SYNDROME; JWS
123155 HYDROCEPHALUS
123320 CREATINE PHOSPHOKINASE, ELEVATED SERUM
123400 CREUTZFELDT-JAKOB DISEASE; CJD
123450 CRI-DU-CHAT SYNDROME
123500 CROUZON SYNDROME
123540 CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY
123550 CRYOGLOBULINEMIA, FAMILIAL MIXED
123557 CRYPTOTIA, FAMILIAL
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME
123570 CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED
123700 CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1
123790 BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS
124000 MITOCHONDRIAL COMPLEX III DEFICIENCY
124100 DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY
124200 DARIER-WHITE DISEASE; DAR
124300 DARWINIAN TUBERCLE OF PINNA
124400 DARWINIAN TUBERCLE OF PINNA
124480 DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY
124500 DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES
124700 DEAFNESS, MID-TONE NEURAL
124900 DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1
124950 DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE
125000 DEAFNESS, UNILATERAL
125050 DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA
125230 DEAFNESS-CRANIOFACIAL SYNDROME
125250 OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY
125260 DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF
125280 DENS EVAGINATUS
125300 DENS IN DENTE AND PALATAL INVAGINATIONS
125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CADASIL
125320 DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES
125350 FAILURE OF TOOTH ERUPTION, PRIMARY; PFE
125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
125400 DENTIN DYSPLASIA, TYPE I; DTDP1
125420 DENTIN DYSPLASIA, TYPE II
125440 DENTIN DYSPLASIA WITH SCLEROTIC BONES
125480 MAJOR AFFECTIVE DISORDER 1; MAFD1
125490 DENTINOGENESIS IMPERFECTA 1; DGI1
125500 DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III
125520 CAYLER CARDIOFACIAL SYNDROME
125530 DERMAL RIDGES, NELSON SYNDROME
125540 DERMAL RIDGES, PATTERNLESS
125550 DERMAL RIDGES-OFF-THE-END; ROES
125570 DERMATOGLYPHICS--ARCH ON ANY DIGIT
125590 DERMATOGLYPHICS--FINGERPRINT PATTERN
125595 DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR
125600 DERMATOSIS PAPULOSA NIGRA
125630 DERMODISTORTIVE URTICARIA; DDU
125635 DERMOGRAPHISM, FAMILIAL
125640 DERMOODONTODYSPLASIA
125700 DIABETES INSIPIDUS, NEUROHYPOPHYSEAL
125800 DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL
125850 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
125851 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2
125852 DIABETES MELLITUS, INSULIN-DEPENDENT, 2
125853 DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
125900 DIASTEMA, DENTAL MEDIAL
126050 DIGITOTALAR DYSMORPHISM
126070 DILUTION, PIGMENTARY
126100 DIMPLES, FACIAL
126190 DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS
126200 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
126250 DISTAL OSTEOSCLEROSIS
126300 DISTICHIASIS
126320 DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE
126600 DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD
126700 BASAL LAMINAR DRUSEN
126800 DUANE RETRACTION SYNDROME 1; DURS1
126840 DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION
126850 DUODENAL ULCER, HYPERPEPSINOGENEMIC I
126900 DUPUYTREN CONTRACTURE DUPUYTREN CONTRACTURE 1, INCLUDED; DUPC1, INCLUDED
126950 DWARFISM WITH TALL VERTEBRAE
127000 KENNY-CAFFEY SYNDROME, TYPE 2
127100 DWARFISM, LEVI TYPE
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES
127300 LERI-WEILL DYSCHONDROSTEOSIS; LWD
127350 DYSCHONDROSTEOSIS AND NEPHRITIS
127400 DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1
127500 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1
127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1
127600 DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL
127700 DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1
127750 DEMENTIA, LEWY BODY; DLB
127800 DYSPLASIA EPIPHYSEALIS HEMIMELICA
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS
128000 DYSTELEPHALANGY
128100 DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1
128101 DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4
128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1
128230 DYSTONIA, DOPA-RESPONSIVE; DRD
128235 DYSTONIA 12; DYT12
128290 EAR ANTITRAGUS, TAG AT BASE OF
128300 EAR EXOSTOSES
128400 EAR FLARE
128500 EAR FOLDING
128600 EAR MALFORMATION
128700 PREAURICULAR FISTULAE, CONGENITAL
128710 EAR PITS, POSTERIOR HELICAL
128800 EAR WITHOUT HELIX
128900 EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED
128950 EARLOBE CREASE
128980 EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES
129000 EARRING HOLES, NATURAL
129100 EARS, ABILITY TO MOVE
129150 ECHO VIRUS 11 SENSITIVITY; E11S
129200 ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES
129400 RAPP-HODGKIN SYNDROME; RHS
129490 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED
129500 ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT
129510 ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET
129550 ECTODERMAL DYSPLASIA WITH ADRENAL CYST
129600 ECTOPIA LENTIS, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1
129750 ECTOPIA PUPILLAE
129810 ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME
129840 EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL
129850 EDINBURGH MALFORMATION SYNDROME
129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1
130000 EHLERS-DANLOS SYNDROME, TYPE I
130010 EHLERS-DANLOS SYNDROME, TYPE II
130020 EHLERS-DANLOS SYNDROME, TYPE III
130050 EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
130060 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
130070 EHLERS-DANLOS SYNDROME, PROGEROID FORM
130080 EHLERS-DANLOS SYNDROME, TYPE VIII
130090 EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED
130100 ELASTOSIS PERFORANS SERPIGINOSA; EPS
130180 ELECTROENCEPHALOGRAM, LOW-VOLTAGE
130190 ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL
130200 ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON
130300 ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS
130400 ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES
130600 ELLIPTOCYTOSIS 2; EL2
130650 BECKWITH-WIEDEMANN SYNDROME; BWS
130700 EMPHYSEMA, HEREDITARY PULMONARY
130710 EMPHYSEMA, CONGENITAL LOBAR; CLE
130720 LATERAL MENINGOCELE SYNDROME
130900 AMELOGENESIS IMPERFECTA, TYPE III; AI3
130950 ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD
131100 MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
131200 ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1
131300 CAMURATI-ENGELMANN DISEASE; CAEND
131400 EOSINOPHILIA, FAMILIAL
131430 EOSINOPHILOPENIA
131440 MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
131445 EPENDYMOMA
131450 EPIBLEPHARON OF LOWER LID
131460 EPIBLEPHARON OF UPPER LID
131500 EPICANTHUS
131600 EPIDERMOID CYSTS
131705 TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
131750 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB
131760 EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE
131800 EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED
131850 EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL
131880 EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE
131900 EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED
131950 EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE
131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP
132000 EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS
132090 EPILEPSY, BENIGN OCCIPITAL; BOE
132100 PHOTOPAROXYSMAL RESPONSE; PPR
132300 EPILEPSY, READING
132400 EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1
132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS
132500 EPISTAXIS, HEREDITARY
132600 PILOMATRIXOMA
132700 CYLINDROMATOSIS, FAMILIAL
132800 MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE
132900 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
132990 ERYTHEMA NODOSUM, FAMILIAL
133000 ERYTHEMA PALMARE HEREDITARIUM
133020 ERYTHERMALGIA, PRIMARY
133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1
133180 ERYTHROLEUKEMIA, FAMILIAL
133190 SPINOCEREBELLAR ATAXIA 34; SCA34
133200 ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP
133239 ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED
133240 ESOPHAGEAL RING, LOWER
133500 EXCHONDROSIS OF PINNA, POSTERIOR
133540 COCKAYNE SYNDROME, TYPE B; CSB
133690 EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E
133700 EXOSTOSES, MULTIPLE, TYPE I
133701 EXOSTOSES, MULTIPLE, TYPE II
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY
133780 EXUDATIVE VITREORETINOPATHY 1; EVR1
133800 EYEBROW, WHORL IN
133900 HEMIFACIAL HYPERPLASIA
134000 FACIAL HYPERTRICHOSIS
134200 FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL
134300 FACIAL SPASM
134400 FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS
134430 FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF
134500 FACTOR VIII DEFICIENCY
134520 FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF
134600 FANCONI RENOTUBULAR SYNDROME 1; FRTS1
134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
134700 FAVISM, SUSCEPTIBILITY TO
134750 FELTY SYNDROME
134780 FEMORAL-FACIAL SYNDROME; FFS
134900 FIBRINOLYTIC DEFECT
135100 FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
135150 BIRT-HOGG-DUBE SYNDROME; BHD
135290 DESMOID DISEASE, HEREDITARY
135300 FIBROMATOSIS, GINGIVAL, 1; GINGF1
135400 HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA
135500 ZIMMERMANN-LABAND SYNDROME; ZLS
135550 FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS
135580 FIBROMUSCULAR DYSPLASIA OF ARTERIES
135700 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1
135750 LAURIN-SANDROW SYNDROME
135800 FIBULA, RECURRENT DISLOCATION OF HEAD OF
135900 COFFIN-SIRIS SYNDROME; CSS
135950 FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE
136000 ADERMATOGLYPHIA; ADERM
136100 FINGERS, RELATIVE LENGTH OF
136120 FISH-EYE DISEASE; FED
136140 FLOATING-HARBOR SYNDROME; FLHS
136200 FLUSHING OF EARS AND SOMNOLENCE
136300 FLYNN-AIRD SYNDROME
136400 FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA
136480 FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL
136500 BRAUER SYNDROME
136520 FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME FOVEAL HYPOPLASIA, ISOLATED, INCLUDED
136550 MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1
136600 FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS
136680 FRASIER SYNDROME
136760 FRONTONASAL DYSPLASIA 1; FND1
136800 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1
136880 FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED
136900 FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD
137000 FUTCHER LINE
137040 GALLBLADDER, AGENESIS OF
137050 GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF
137100 IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1
137130 GASTRIC SNEEZING
137200 GAMSTORP-WOHLFART SYNDROME
137210 GASTRIC VOLVULUS, INTRATHORACIC
137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC
137270 GASTROCUTANEOUS SYNDROME
137280 GASTRITIS, FAMILIAL GIANT HYPERTROPHIC
137370 GENU VALGUM, ST. HELENA FAMILIAL
137400 GEOGRAPHIC TONGUE AND FISSURED TONGUE GLOSSITIS, BENIGN MIGRATORY, INCLUDED
137440 GERSTMANN-STRAUSSLER DISEASE; GSD
137550 GIANT PIGMENTED HAIRY NEVUS; GPHN
137560 GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA
137575 GIGANTIFORM CEMENTOMA, FAMILIAL
137580 GILLES DE LA TOURETTE SYNDROME; GTS
137600 IRIDOGONIODYSGENESIS, TYPE 2; IRID2
137700 GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE
137750 GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760 GLAUCOMA, PRIMARY OPEN ANGLE; POAG GLAUCOMA 1, OPEN ANGLE, E, INCLUDED; GLC1E, INCLUDED
137800 GLIOMA SUSCEPTIBILITY 1; GLM1 GLIOMA OF BRAIN, FAMILIAL, INCLUDED
137900 GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN
137920 RENAL CYSTS AND DIABETES SYNDROME
137940 GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES
137950 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1
138000 GLOMUVENOUS MALFORMATIONS; GVM
138070 GLUCOGLYCINURIA
138500 HYPERGLYCINURIA
138770 GMS SYNDROME
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES
138800 GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1
138900 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1
138920 GRANDDAD SYNDROME
138930 GRANT SYNDROME
138990 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL DOMINANT TYPE
139000 GRANULOSIS RUBRA NASI
139090 GRAY PLATELET SYNDROME; GPS
139100 GRAYING OF HAIR, PRECOCIOUS
139210 MYHRE SYNDROME; MYHRS
139300 AROMATASE EXCESS SYNDROME; AEXS
139393 GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS
139400 HAIR WHORL
139450 HAIR MORPHOLOGY 2; HRM2
139500 HAIRY EARS
139600 HAIRY ELBOWS
139630 HAIRY NOSE TIP
139650 HAIRY PALMS AND SOLES
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES
140000 HAND-FOOT-UTERUS SYNDROME
140300 HASHIMOTO THYROIDITIS
140350 HAWKINSINURIA
140400 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2
140450 HEART-HAND SYNDROME, SPANISH TYPE
140500 HEART, MALFORMATION OF
140600 OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2
140700 HEINZ BODY ANEMIAS
140850 HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE
140900 HEMANGIOMAS OF SMALL INTESTINE
141000 HEMANGIOMA-THROMBOCYTOPENIA SYNDROME
141200 HEMATURIA, BENIGN FAMILIAL; BFH
141300 HEMIFACIAL ATROPHY, PROGRESSIVE; HFA
141350 HEMIFACIAL HYPERPLASIA WITH STRABISMUS
141400 HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS
141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1
141700 HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES
141750 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED
142309 HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN
142330 HEPATIC ADENOMAS, FAMILIAL
142340 DIAPHRAGMATIC HERNIA, CONGENITAL
142350 HERNIA, DOUBLE INGUINAL
142395 HEPATITIS B VACCINE, RESPONSE TO
142400 HERNIA, HIATUS
142500 HETEROCHROMIA IRIDIS
142623 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1
142625 HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION
142630 HISTIOCYTOSIS, PROGRESSIVE MUCINOUS
142669 HIP DYSPLASIA, BEUKES TYPE
142680 PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT
142690 ACNE INVERSA, FAMILIAL, 1; ACNINV1
142700 ACETABULAR DYSPLASIA HIP, DISLOCATION OF, CONGENITAL, INCLUDED
142900 HOLT-ORAM SYNDROME; HOS
142945 HOLOPROSENCEPHALY 3; HPE3
142946 HOLOPROSENCEPHALY 4; HPE4
143000 HORNER SYNDROME, CONGENITAL
143050 HUMERORADIAL SYNOSTOSIS
143095 SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS
143100 HUNTINGTON DISEASE; HD
143200 WAGNER SYNDROME 1; WGN1
143400 MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD
143465 ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
143470 HYPERALPHALIPOPROTEINEMIA 1; HALP1
143500 GILBERT SYNDROME
143850 ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
143870 HYPERCALCIURIA, ABSORPTIVE, 2; HCA2
143880 HYPERCALCEMIA, INFANTILE
143890 HYPERCHOLESTEROLEMIA, FAMILIAL
144010 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B
144050 HYPERHEPARINEMIA
144100 HYPERHIDROSIS, GUSTATORY; HYPRG
144110 HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROME IMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR
144150 HYPERKERATOSIS LENTICULARIS PERSTANS; HLP
144200 PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK
144250 HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL
144300 HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS
144600 HYPERLIPOPROTEINEMIA, TYPE IV
144650 HYPERLIPOPROTEINEMIA, TYPE V
144700 RENAL CELL CARCINOMA, NONPAPILLARY; RCC
144750 HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS
144755 HYPEROSTOSIS CRANIALIS INTERNA
144800 HYPEROSTOSIS FRONTALIS INTERNA
145000 HYPERPARATHYROIDISM 1; HRPT1
145001 HYPERPARATHYROIDISM 2; HRPT2
145100 HYPERPIGMENTATION OF EYELIDS
145200 HYPERPIGMENTATION OF FULDAUER AND KUIJPERS
145250 HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2; FPH2
145260 PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A
145290 HYPERREFLEXIA; HRX
145295 HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL
145300 HYPERSENSITIVITY PNEUMONITIS, FAMILIAL
145350 HYPERTAURINURIC CARDIOMYOPATHY
145400 HYPERTELORISM
145410 OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT
145420 HYPERTELORISM, TEEBI TYPE
145500 HYPERTENSION, ESSENTIAL
145590 HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA
145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1
145650 THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH
145680 DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA
145700 HYPERTRICHOSIS UNIVERSALIS
145701 HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1
145750 HYPERTRIGLYCERIDEMIA, FAMILIAL
145800 HYPERTROPHIA MUSCULORUM VERA
145900 HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
145980 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1
145981 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2
146000 HYPOCHONDROPLASIA; HCH
146110 HYPOGONADOTROPIC HYPOGONADISM
146160 HYPOMELIA WITH MULLERIAN DUCT ANOMALIES
146200 HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH
146255 HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR
146300 HYPOPHOSPHATASIA, ADULT
146350 HYPOPHOSPHATEMIC BONE DISEASE; HBD
146390 CHROMOSOME 18p DELETION SYNDROME
146400 HYPOPLASIA OF TEETH ROOTS
146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3
146500 MULTIPLE SYSTEM ATROPHY; MSA AUTONOMIC FAILURE, PURE, INCLUDED
146510 PALLISTER-HALL SYNDROME; PHS
146520 HYPOTRICHOSIS 2; HYPT2
146550 HYPOTRICHOSIS 4; HYPT4
146590 ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM
146600 ICHTHYOSIS HYSTRIX GRAVIOR
146700 ICHTHYOSIS VULGARIS
146720 ICHTHYOSIS--CHEEK--EYEBROW SYNDROME
146750 ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT
146800 ICHTHYOSIS, BULLOUS TYPE
146830 IMMUNE DEFICIENCY, FAMILIAL VARIABLE
146840 IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST
146850 IMMUNE SUPPRESSION; IS
147050 IgE RESPONSIVENESS, ATOPIC; IGER
147060 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT
147250 SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
147251 INCISORS, FUSED MANDIBULAR
147300 INCISORS, LONG UPPER CENTRAL
147330 INCISORS, LOWER CENTRAL, ABSENCE OF
147350 INCISORS, ROTATION OF UPPER CENTRAL
147400 INCISORS, SHOVEL-SHAPED
147421 INCLUSION BODY MYOSITIS
147430 INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT
147480 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY; ICP
147540 INSECT STINGS, HYPERSENSITIVITY TO
147610 IRIS PIGMENT LAYER, CLEAVAGE OF
147630 ISLET CELL ADENOMATOSIS
147710 INTUSSUSCEPTION
147750 IVIC SYNDROME
147770 JOHNSON NEUROECTODERMAL SYNDROME
147791 JACOBSEN SYNDROME; JBS
147800 AASE-SMITH SYNDROME I
147820 INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF
147891 SMALL PATELLA SYNDROME; SPS
147900 JOINT LAXITY, FAMILIAL
147920 KABUKI SYNDROME 1; KABUK1
147950 KALLMANN SYNDROME 2; KAL2
148000 KAPOSI SARCOMA
148050 KBG SYNDROME; KBGS
148100 KELOID FORMATION
148190 KERATITIS, HEREDITARY
148200 KERATITIS FUGAX HEREDITARIA
148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT
148300 KERATOCONUS 1; KTCN1
148350 KERATODERMA, PALMOPLANTAR, WITH DEAFNESS
148360 KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY
148370 KERATOLYTIC WINTER ERYTHEMA
148390 KERATOSIS, FAMILIAL ACTINIC
148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC
148520 KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY
148600 KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE I; PPKP1
148700 KERATOSIS PALMOPLANTARIS STRIATA I; PPKS1
148730 KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL
148800 KLEEBLATTSCHAEDEL
148820 WAARDENBURG SYNDROME, TYPE 3; WS3
148840 KLEINE-LEVIN HIBERNATION SYNDROME
149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME
149100 KNUCKLE PADS
149200 KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS
149300 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2
149400 HYPEREKPLEXIA, HEREDITARY 1; HKPX1
149500 KYRLE DISEASE
149600 LABIA MINORA, INCOMPLETE ADHESION OF
149700 LACRIMAL DUCT DEFECT
149730 LACRIMOAURICULODENTODIGITAL SYNDROME; LADD
150170 LACTIC ACIDOSIS, CHRONIC ADULT FORM
150230 TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2
150250 LARSEN SYNDROME; LRS
150260 LARYNGEAL ABDUCTOR PARALYSIS
150270 LARYNGEAL ADDUCTOR PARALYSIS; LAP
150280 LARYNGOMALACIA
150300 LARYNX, CONGENITAL PARTIAL ATRESIA OF
150360 LARYNGEAL WEB, FAMILIAL
150400 TOOTH AGENESIS, SELECTIVE, 4; STHAG4
150500 LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT
150550 LAZY LEUKOCYTE SYNDROME
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET
150600 LEGG-CALVE-PERTHES DISEASE; LCPD
150699 LEIOMYOMA, UTERINE; UL
150700 LEIOMYOMA OF VULVA AND ESOPHAGUS
150800 HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC
150900 LENTIGINES
151000 LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC
151001 LENTIGINOSIS, INHERITED PATTERNED
151050 LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM
151100 LEOPARD SYNDROME 1
151200 LERI PLEONOSTEOSIS
151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT
151380 LEUKEMIA, ACUTE MONOCYTIC
151400 LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL
151590 LICHEN SCLEROSUS ET ATROPHICUS; LSA
151600 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3
151610 LEVATOR-MEDIAL RECTUS SYNKINESIS
151620 LICHEN PLANUS, FAMILIAL
151623 LI-FRAUMENI SYNDROME 1; LFS1
151630 LIP, MEDIAN NODULE OF UPPER
151640 LIP, HAMARTOMATOUS
151660 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2
151700 LIPOMA OF THE CONJUNCTIVA
151800 LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL
151900 LIPOMATOSIS, MULTIPLE
152420 LITHIUM TRANSPORT
152550 LUMBAR STENOSIS, FAMILIAL
152600 LUNULAE OF FINGERNAILS
152700 SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED
152800 LYMPHANGIECTASIA, INTESTINAL
152900 LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY
152950 MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR
153100 LYMPHEDEMA, HEREDITARY, IA
153200 LYMPHEDEMA, HEREDITARY, II
153300 YELLOW NAIL SYNDROME
153400 LYMPHEDEMA-DISTICHIASIS SYNDROME
153470 MACROCEPHALY, BENIGN FAMILIAL
153480 BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS
153550 CHROMOSOME 5q DELETION SYNDROME
153600 MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1
153630 MACROGLOSSIA
153640 FECHTNER SYNDROME; FTNS
153650 EPSTEIN SYNDROME
153670 BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2
153700 MACULAR DYSTROPHY, VITELLIFORM; VMD
153800 MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2
153840 MACULAR DYSTROPHY, ATYPICAL VITELLIFORM; VMD1
153870 MACULAR DYSTROPHY, CONCENTRIC ANNULAR
153880 MACULAR EDEMA, CYSTOID
153890 MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE
154000 MACULES, HEREDITARY CONGENITAL HYPOPIGMENTED AND HYPERPIGMENTED
154020 HYPOMAGNESEMIA 2, RENAL; HOMG2
154230 46,XY SEX REVERSAL 4; SRXY4
154275 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2
154276 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3
154300 MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH
154400 ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1
154500 TREACHER COLLINS SYNDROME 1; TCS1
154600 MARCUS GUNN PHENOMENON
154700 MARFAN SYNDROME; MFS
154750 MARFANOID HYPERMOBILITY SYNDROME
154780 MARSHALL SYNDROME; MRSHS
154800 MAST CELL DISEASE
154850 MASTICATORY MUSCLES, HYPERTROPHY OF
155000 MAXILLOFACIAL DYSOSTOSIS
155050 MAXILLONASAL DYSPLASIA, BINDER TYPE
155100 MAY-HEGGLIN ANOMALY; MHA
155140 MECKEL DIVERTICULUM
155145 CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
155200 MEDIOSTERNAL DEPIGMENTATION LINE
155240 THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
155255 MEDULLOBLASTOMA; MDB MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED
155310 MEGADUODENUM AND/OR MEGACYSTIS PSEUDOOBSTRUCTION, IDIOPATHIC INTESTINAL
155350 MEGALENCEPHALY
155500 MEGALODACTYLY
155600 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1
155601 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2
155700 MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR
155720 MELANOMA, UVEAL
155755 MELANOMA-ASTROCYTOMA SYNDROME
155800 MELANOSIS, UNIVERSAL
155900 MELKERSSON-ROSENTHAL SYNDROME
155950 MELORHEOSTOSIS, ISOLATED
156000 MENIERE DISEASE
156190 MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA
156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1 CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED
156230 MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE
156232 MESOMELIC DYSPLASIA, KANTAPUTRA TYPE
156240 MESOTHELIOMA, MALIGNANT; MESOM
156250 METACHONDROMATOSIS; METCDS
156310 METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A
156400 METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE
156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS
156510 METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY
156520 METATARSUS VARUS, TYPE I
156530 METATROPIC DYSPLASIA
156550 KNIEST DYSPLASIA
156580 MICROCEPHALY, AUTOSOMAL DOMINANT
156600 MICROCORIA, CONGENITAL
156610 SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS
156620 MICROCEPHALY-DEAFNESS SYNDROME
156700 MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES
156810 MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD
156830 MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL
156850 MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1
156900 MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR
157150 MICROSPHEROPHAKIA WITH HERNIA
157151 MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA
157170 HOLOPROSENCEPHALY 2; HPE2
157200 MIDPHALANGEAL HAIR
157300 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
157400 MILIA, MULTIPLE ERUPTIVE
157600 MIRROR MOVEMENTS 1; MRMV1
157640 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1; PEOA1
157700 MITRAL VALVE PROLAPSE, FAMILIAL; MVP
157800 MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES
157900 MOEBIUS SYNDROME; MBS
157950 PERMANENT MOLARS, SECONDARY RETENTION OF
157980 MOMO SYNDROME
158000 MONILETHRIX
158170 CHROMOSOME 9p DELETION SYNDROME
158250 NONDISJUNCTION
158300 ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7
158310 MUCOEPITHELIAL DYSPLASIA, HEREDITARY
158320 MUIR-TORRE SYNDROME; MRTES
158330 MULLERIAN APLASIA AND HYPERANDROGENISM
158345 MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS
158350 COWDEN DISEASE; CD
158400 MUSCLE CRAMPS, FAMILIAL
158500 MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS
158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A
158590 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A
158600 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT; SMALED
158650 MUSCULAR ATROPHY, MALIGNANT NEUROGENIC
158800 MUSCULAR DYSTROPHY, BARNES TYPE
158810 BETHLEM MYOPATHY
158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A
159000 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A
159001 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B
159050 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE
159300 MUSICAL PERFECT PITCH
159400 MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE
159410 MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS
159420 MYDRIASIS, CONGENITAL
159500 MYELINATED OPTIC NERVE FIBERS
159550 MYELOCEREBELLAR DISORDER
159580 MYELOPATHY, HTLV-1-ASSOCIATED; HAM
159595 MYELOPROLIFERATIVE SYNDROME, TRANSIENT
159600 MYOCLONIC EPILEPSY, HARTUNG TYPE
159700 MYOCLONUS AND ATAXIA
159800 MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS
159900 MYOCLONIC DYSTONIA
159950 SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME
160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT
160120 EPISODIC ATAXIA, TYPE 1; EA1
160150 MYOPATHY, CENTRONUCLEAR, 1; CNM1
160300 MYOPATHY, DISTAL, WITH ONSET IN INFANCY
160500 MYOPATHY, DISTAL, 1; MPD1
160565 MYOPATHY, TUBULAR AGGREGATE
160570 MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS
160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2
160750 MYOSITIS
160800 MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
160900 MYOTONIC DYSTROPHY 1; DM1
160980 CARNEY COMPLEX, TYPE 1; CNC1
160990 MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS
161000 NAEGELI SYNDROME
161050 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1
161070 NAIL HIGH-SULFUR PROTEIN
161080 NAIL LOW-SULFUR PROTEIN
161100 NAILBEDS, PIGMENTATION OF
161200 NAIL-PATELLA SYNDROME; NPS
161400 NARCOLEPSY 1; NRCLP1
161470 NASAL ALAR COLLAPSE, BILATERAL
161480 NASAL BONES, ABSENCE OF
161500 NASAL GROOVE, FAMILIAL TRANSVERSE
161530 NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE
161550 NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2
161700 NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT
161800 NEMALINE MYOPATHY 3; NEM3 MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS, INCLUDED
161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION
161950 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1
162000 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1
162091 SCHWANNOMATOSIS
162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA
162200 NEUROFIBROMATOSIS, TYPE I; NF1
162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL
162240 NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME
162260 NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A
162270 NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4
162300 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B
162350 CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B
162370 NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX
162380 NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE
162400 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A
162500 NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
162600 NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE
162700 NEUTROPENIA, CHRONIC FAMILIAL
162800 CYCLIC NEUTROPENIA
162820 NEUTROPHIL MIGRATION; NM
162830 NEUTROPHILIA, HEREDITARY
162900 NEVUS, EPIDERMAL
163000 CAPILLARY MALFORMATIONS, CONGENITAL, 1
163050 NEVUS ANEMICUS
163100 NEVUS FLAMMEUS OF NAPE OF NECK
163200 SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM
163400 NIEVERGELT SYNDROME
163500 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
163600 NIPPLES INVERTED
163700 NIPPLES, SUPERNUMERARY
163800 SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT; SSS2
163850 NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES
163950 NOONAN SYNDROME 1; NS1
164000 NOSE, ANOMALOUS SHAPE OF
164100 NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2
164150 NYSTAGMUS, HEREDITARY VERTICAL
164170 NYSTAGMUS, VOLUNTARY
164180 OCULOCEREBROCUTANEOUS SYNDROME
164185 OCULAR CICATRICIAL PEMPHIGOID; OCP
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
164210 HEMIFACIAL MICROSOMIA; HFM
164220 SCHILBACH-ROTT SYNDROME
164230 OBSESSIVE-COMPULSIVE DISORDER; OCD
164280 FEINGOLD SYNDROME 1; FGLDS1
164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD
164310 OCULOPHARYNGODISTAL MYOPATHY; OPDM
164330 ODONTOMA-DYSPHAGIA SYNDROME
164400 SPINOCEREBELLAR ATAXIA 1; SCA1
164500 SPINOCEREBELLAR ATAXIA 7; SCA7
164680 ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V
164745 OMODYSPLASIA 2; OMOD2
164750 OMPHALOCELE, AUTOSOMAL
164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5
164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA
165000 OPHTHALMOPLEGIA, FAMILIAL STATIC
165098 OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION
165150 OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY
165199 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS
165300 OPTIC ATROPHY 3, AUTOSOMAL DOMINANT
165500 OPTIC ATROPHY 1; OPA1
165510 OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS
165550 OPTIC NERVE HYPOPLASIA, BILATERAL OPTIC NERVE APLASIA, BILATERAL, INCLUDED
165590 OROFACIODIGITAL SYNDROME X; OFD10
165600 ORBITAL MARGIN, HYPOPLASIA OF
165660 OSLAM SYNDROME
165670 OSSIFIED EAR CARTILAGES
165680 OSSICULAR MALFORMATIONS, FAMILIAL
165700 THIEMANN DISEASE
165720 OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1
165800 OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD
166000 ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE
166200 OSTEOGENESIS IMPERFECTA, TYPE I
166210 OSTEOGENESIS IMPERFECTA, TYPE II
166220 OSTEOGENESIS IMPERFECTA, TYPE IV
166230 OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES
166250 OSTEOGLOPHONIC DYSPLASIA; OGD
166260 GNATHODIAPHYSEAL DYSPLASIA; GDD
166300 MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO
166350 OSSEOUS HETEROPLASIA, PROGRESSIVE; POH
166400 OSTEOMAS OF MANDIBLE
166450 OSTEOMESOPYKNOSIS
166600 OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2
166700 BUSCHKE-OLLENDORFF SYNDROME; BOS
166705 OSTEOPOIKILOSIS AND DACRYOCYSTITIS
166710 OSTEOPOROSIS
166740 OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES
166750 OTODENTAL DYSPLASIA
166760 OTITIS MEDIA, SUSCEPTIBILITY TO
166780 OTOFACIOCERVICAL SYNDROME
166800 OTOSCLEROSIS 1; OTSC1
166900 OVALOCYTOSIS, HEREDITARY HEMOLYTIC
166910 OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS
166950 TERATOMA, OVARIAN
166970 OVARIAN FIBROMATA
166990 OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION
167000 OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
167030 NEPHROLITHIASIS, CALCIUM OXALATE
167100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD
167200 PACHYONYCHIA CONGENITA, TYPE 1; PC1
167210 PACHYONYCHIA CONGENITA, TYPE 2; PC2
167220 PACMAN DYSPLASIA
167250 PAGET DISEASE OF BONE 1; PDB1
167300 PAGET DISEASE, EXTRAMAMMARY
167320 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA; IBMPFD
167400 PAROXYSMAL EXTREME PAIN DISORDER
167500 PALATOPHARYNGEAL INCOMPETENCE
167730 PALPEBRAL COLOBOMA-LIPOMA SYNDROME
167750 PANCREAS, ANNULAR
167800 PANCREATITIS, HEREDITARY; PCTT
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE
167870 PANIC DISORDER 1; PAND1
167900 PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP
167950 PAPILLOMATOSIS, FLORID, OF NIPPLE
168000 PARAGANGLIOMAS 1; PGL1
168100 PARALYSIS AGITANS, JUVENILE, OF HUNT
168200 PARAMOLAR TUBERCLE OF BOLK
168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC
168400 PARASTREMMATIC DWARFISM
168500 PARIETAL FORAMINA; PFM
168550 PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD
168600 PARKINSON DISEASE, LATE-ONSET; PD
168605 PERRY SYNDROME
168800 PAROTIDOMEGALY, HEREDITARY BILATERAL
168830 PASSOVOY FACTOR DEFECT
168850 PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS
168860 PATELLA APLASIA-HYPOPLASIA; PTLAH
168885 PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA
168900 PATELLA, CHONDROMALACIA OF
169000 PATELLA, FAMILIAL RECURRENT DISLOCATION OF
169100 CHAR SYNDROME
169150 PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
169170 PATTERSON PSEUDOLEPRECHAUNISM SYNDROME
169200 PECHET FACTOR DEFICIENCY
169300 PECTUS EXCAVATUM
169400 PELGER-HUET ANOMALY; PHA
169500 LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD
169545 PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA
169550 PELVIS-SHOULDER DYSPLASIA
169600 BENIGN CHRONIC PEMPHIGUS; BCPM
169610 PEMPHIGUS VULGARIS, FAMILIAL
170100 PROLIDASE DEFICIENCY
170390 ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS
170400 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1
170500 HYPERKALEMIC PERIODIC PARALYSIS; HYPP
170600 NORMOKALEMIC PERIODIC PARALYSIS
170650 PERIODONTITIS, AGGRESSIVE, 1
170700 PERIPHERAL DYSOSTOSIS
170900 PERNICIOUS ANEMIA
171000 PEYRONIE DISEASE
171200 THIOUREA TASTING PHENYLTHIOCARBAMIDE TASTING, INCLUDED
171300 PHEOCHROMOCYTOMA PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
171400 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A
171420 PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME
171450 PHLEBECTASIA OF LIPS
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA
172150 6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION
172700 PICK DISEASE OF BRAIN
172800 PIEBALD TRAIT; PBT
172850 PIEBALD TRAIT WITH NEUROLOGIC DEFECTS
172870 PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA
172880 PIERRE ROBIN SYNDROME AND OLIGODACTYLY
172900 PIGMENTED PURPURIC ERUPTION
173000 PILONIDAL SINUS
173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2
173200 PITYRIASIS RUBRA PILARIS; PRP
173400 PLATELET AGGREGATION, SPONTANEOUS
173420 PLATELET DISORDER, UNDEFINED
173450 PLATELET FACTOR 3 DEFICIENCY
173580 PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED
173590 PLATELET SIGNAL PROCESSING DEFECT
173600 PNEUMOTHORAX, PRIMARY SPONTANEOUS
173650 KINDLER SYNDROME
173700 POIKILODERMA, HEREDITARY SCLEROSING
173800 POLAND SYNDROME
173900 POLYCYSTIC KIDNEY DISEASE 1; PKD1
174000 MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1
174050 POLYCYSTIC LIVER DISEASE; PCLD
174200 POLYDACTYLY, POSTAXIAL, TYPE A1
174300 OROFACIODIGITAL SYNDROME V; OFD5
174310 POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA
174400 POLYDACTYLY, PREAXIAL I
174500 POLYDACTYLY, PREAXIAL II; PPD2
174600 POLYDACTYLY, PREAXIAL III
174700 POLYDACTYLY, PREAXIAL IV
174770 ACTINIC PRURIGO POLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE
174800 MCCUNE-ALBRIGHT SYNDROME; MAS
174810 FAMILIAL EXPANSILE OSTEOLYSIS; FEO
174900 JUVENILE POLYPOSIS SYNDROME; JPS
175020 POLYPOSIS, GASTRIC
175050 JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT
175100 FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
175200 PEUTZ-JEGHERS SYNDROME; PJS
175400 POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE
175450 POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES
175505 POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI
175510 POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL
175700 GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
175750 POPLITEAL CYST
175780 PORENCEPHALY 1; POREN1
175800 POROKERATOSIS OF MIBELLI
175850 POROKERATOSIS, PALMAR, PLANTAR, AND DISSEMINATED, 1; PPPD1
175860 KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II; PPKP2
175900 POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1; DSAP1
176000 PORPHYRIA, ACUTE INTERMITTENT
176090 PORPHYRIA CUTANEA TARDA, TYPE I
176100 PORPHYRIA CUTANEA TARDA
176200 PORPHYRIA VARIEGATA
176240 POSTAXIAL OLIGODACTYLY, TETRAMELIC
176250 POSTERIOR COLUMN ATAXIA
176270 PRADER-WILLI SYNDROME; PWS
176305 PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS
176400 PRECOCIOUS PUBERTY, CENTRAL
176410 PRECOCIOUS PUBERTY, MALE-LIMITED
176430 PREMATURE CHROMATID SEPARATION TRAIT; PCS
176450 CURRARINO SYNDROME
176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1
176600 PRESENILE DEMENTIA, KRAEPELIN TYPE
176620 PRIAPISM, FAMILIAL IDIOPATHIC
176630 PRIMARY RELEASE DISORDER OF PLATELETS
176670 HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
176690 PROGEROID SHORT STATURE WITH PIGMENTED NEVI
176700 PROGNATHISM, MANDIBULAR
176780 PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO
176800 PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF
176807 PROSTATE CANCER
176860 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3
176920 PROTEUS SYNDROME
177000 PROTOPORPHYRIA, ERYTHROPOIETIC; EPP
177050 PROTRUSIO ACETABULI
177100 PRURITUS, HEREDITARY LOCALIZED
177170 PSEUDOACHONDROPLASIA; PSACH
177200 LIDDLE SYNDROME
177300 PSEUDOARTHROGRYPOSIS
177350 PSEUDOATROPHODERMA COLLI
177650 EXFOLIATION SYNDROME; XFS
177700 PSEUDOGLAUCOMA
177720 PSEUDOHYPERKALEMIA, FAMILIAL, 1, DUE TO RED CELL LEAK
177820 PSEUDO-VON WILLEBRAND DISEASE; VWDP
177850 PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE PSEUDOXANTHOMA ELASTICUM, HETEROZYGOUS, INCLUDED
177900 PSORIASIS SUSCEPTIBILITY 1; PSORS1
177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES
177990 PTERYGIUM COLLI, ISOLATED
178000 PTERYGIUM OF CONJUNCTIVA AND CORNEA
178110 ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8
178200 PTERYGIUM, ANTECUBITAL
178300 PTOSIS, HEREDITARY CONGENITAL 1; PTOS1
178330 PTOSIS, STRABISMUS, AND ECTOPIC PUPILS
178370 PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT
178400 PULMONARY EDEMA OF MOUNTAINEERS
178500 PULMONARY FIBROSIS, IDIOPATHIC; IPF
178550 PULMONARY HEMOSIDEROSIS
178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL
178650 PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES
178651 PULMONIC STENOSIS AND DEAFNESS
178800 PUPIL, EGG-SHAPED
178900 PUPILLARY MEMBRANE, PERSISTENCE OF
178995 PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP
179000 PURPURA SIMPLEX
179010 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1
179200 RADIAL HEADS, POSTERIOR DISLOCATION OF
179250 RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA
179270 RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA
179280 RADIAL-RENAL SYNDROME
179300 RADIOULNAR SYNOSTOSIS
179400 RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE
179450 RAGWEED SENSITIVITY
179500 RAINDROP HYPOPIGMENTATION
179613 RECOMBINANT CHROMOSOME 8 SYNDROME
179650 RED CELL PERMEABILITY DEFECT
179700 RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS
179800 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL
179840 RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
179850 DOWLING-DEGOS DISEASE; DDD
179900 RETINAL APLASIA
180020 RETINAL CONE DYSTROPHY 1; RCD1
180050 RETINAL DETACHMENT
180070 RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT
180080 RETINAL VENOUS BEADING
180100 RETINITIS PIGMENTOSA 1; RP1
180104 RETINITIS PIGMENTOSA 9; RP9
180105 RETINITIS PIGMENTOSA 10; RP10
180200 RETINOBLASTOMA; RB1
180210 RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT
180270 RETINOSCHISIS, AUTOSOMAL DOMINANT
180300 RHEUMATOID ARTHRITIS; RA
180350 RHEUMATOID NODULOSIS
180360 RHINY
180500 AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1
180600 RINGED HAIR
180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS
180730 ROMBO SYNDROME
180750 ROBINOW-SORAUF SYNDROME
180800 ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA
180849 RUBINSTEIN-TAYBI SYNDROME 1; RSTS1
180860 SILVER-RUSSELL SYNDROME; SRS
180870 RUVALCABA SYNDROME
180900 RUTHERFURD SYNDROME
180920 APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG
181000 SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1
181010 SALIVARY DUCT CALCULI
181030 SALIVARY GLAND ADENOMA, PLEOMORPHIC
181180 SAY SYNDROME
181250 SCALP DEFECTS AND POSTAXIAL POLYDACTYLY
181270 SCALP-EAR-NIPPLE SYNDROME
181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2
181400 SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK
181405 SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA
181430 SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM
181440 SCHEUERMANN DISEASE
181450 ULNAR-MAMMARY SYNDROME; UMS
181460 SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO
181500 SCHIZOPHRENIA; SCZD
181510 SCHIZOPHRENIA 1; SCZD1
181515 SCHOLTE SYNDROME
181600 SCLEROTYLOSIS
181700 SCLEROCORNEA, AUTOSOMAL DOMINANT
181750 SCLERODERMA, FAMILIAL PROGRESSIVE
181800 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1; IS1
182000 KERATOSIS, SEBORRHEIC
182150 SIMOSA CRANIOFACIAL SYNDROME
182170 ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT
182190 SINUS NODE DISEASE AND MYOPIA
182200 SELLA TURCICA, BRIDGED
182210 SHPRINTZEN OMPHALOCELE SYNDROME
182212 SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME
182230 SEPTOOPTIC DYSPLASIA
182250 SINGLETON-MERTEN SYNDROME
182255 SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION
182260 SLIPPED FEMORAL CAPITAL EPIPHYSES
182280 SMALL CELL CANCER OF THE LUNG
182290 SMITH-MAGENIS SYNDROME; SMS
182410 SNEDDON SYNDROME
182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A
182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR
182690 SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY
182800 SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS
182815 SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA
182820 SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY
182830 SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA
182875 SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND TRANSVERSE EARLOBE CREASE
182900 SPHEROCYTOSIS, TYPE 1; SPH1
182920 MYOPATHY, SPHEROID BODY
182940 NEURAL TUBE DEFECTS
182950 SPINAL ARACHNOIDITIS
182960 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I; HMN1
182970 SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE
182980 SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED
182990 SPINAL INTRADURAL ARACHNOID CYSTS
183020 SPINAL MUSCULAR ATROPHY, SEGMENTAL
183050 SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY
183086 SPINOCEREBELLAR ATAXIA 6; SCA6
183090 SPINOCEREBELLAR ATAXIA 2; SCA2
183100 SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS
183300 SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA
183350 SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T-HELPER CELLS
183400 SPLIT LOWER LIP
183500 SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA
183600 SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
183700 SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS
183840 SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2
183849 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS
183850 SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY
183900 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS
184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
184100 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT
184200 SPONDYLOLISTHESIS
184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK
184252 SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
184253 SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE
184255 SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE
184260 SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
184300 SPONDYLOSIS, CERVICAL
184400 SPRENGEL DEFORMITY
184450 STUTTERING, FAMILIAL PERSISTENT, 1; STUT1
184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES
184500 STEATOCYSTOMA MULTIPLEX
184510 STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH
184700 POLYCYSTIC OVARY SYNDROME 1; PCOS1
184705 STEINFELD SYNDROME
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF
184840 STICKLER SYNDROME, TYPE III; STL3
184850 STIFF-PERSON SYNDROME; SPS
184900 STIFF SKIN SYNDROME; SSKS
185000 STOMATOCYTOSIS I
185010 STOMATOCYTOSIS II
185020 PSEUDOHYPERKALEMIA CARDIFF
185050 STORAGE POOL PLATELET DISEASE
185069 STORM SYNDROME
185070 STORMORKEN SYNDROME
185100 STRABISMUS, SUSCEPTIBILITY TO STRABISMUS, SUSCEPTIBILITY TO, 1, INCLUDED; STBMS1, INCLUDED
185200 STRIAE DISTENSAE, FAMILIAL
185300 STURGE-WEBER SYNDROME; SWS
185460 SULFHEMOGLOBINEMIA, CONGENITAL
185480 SUPRABULBAR PARESIS, CONGENITAL
185500 SUPRAVALVULAR AORTIC STENOSIS; SVAS
185600 SYMPHALANGISM OF TOES
185650 SYMPHALANGISM, C. S. LEWIS TYPE
185700 SYMPHALANGISM, DISTAL
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET
185800 SYMPHALANGISM, PROXIMAL; SYM1
185900 SYNDACTYLY, TYPE I
186000 SYNPOLYDACTYLY 1; SPD1
186100 SYNDACTYLY, TYPE III
186200 SYNDACTYLY, TYPE IV
186300 SYNDACTYLY, TYPE V
186350 SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME
186400 SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL
186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1
186550 SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY
186570 TARSAL-CARPAL COALITION SYNDROME; TCC SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED
186575 SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM
186580 BLAU SYNDROME
186600 SYRINGOMAS, MULTIPLE
186700 SYRINGOMYELIA, ISOLATED
186750 TALONAVICULAR COALITION
186850 TARSAL COALITION
187000 TEETH, ODD SHAPES OF LOBODONTIA, INCLUDED
187050 TEETH PRESENT AT BIRTH
187100 TEETH, SUPERNUMERARY
187260 TELANGIECTASIA, HEREDITARY BENIGN
187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT
187350 TELECANTHUS
187360 TEMPORAL ARTERITIS
187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10
187390 TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF
187400 TESTICULAR TORSION
187500 TETRALOGY OF FALLOT; TOF
187501 TETRALOGY OF FALLOT AND GLAUCOMA
187510 TETRAMELIC MONODACTYLY
187550 THALASSEMIA, BETA+, SILENT ALLELE
187600 THANATOPHORIC DYSPLASIA, TYPE I; TD1
187601 THANATOPHORIC DYSPLASIA, TYPE II; TD2
187750 THORACIC DYSOSTOSIS, ISOLATED
187760 THORACOLARYNGOPELVIC DYSPLASIA; TLPD
187770 THORACOPELVIC DYSOSTOSIS
187800 GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT
187900 THROMBASTHENIA-THROMBOCYTOPENIA, HEREDITARY
187950 THROMBOCYTHEMIA 1; THCYT1
188000 THROMBOCYTOPENIA 2; THC2
188020 THROMBOCYTOPENIA, CYCLIC
188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP
188050 THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1
188055 THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2
188100 THUMB DEFORMITY
188150 THUMB DEFORMITY AND ALOPECIA
188201 THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY
188400 DIGEORGE SYNDROME; DGS
188470 THYROID CARCINOMA, FOLLICULAR; FTC
188550 THYROID CARCINOMA, PAPILLARY
188560 THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT
188570 THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH
188580 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1
188700 BLOUNT DISEASE, INFANTILE
188740 TIBIA, ABSENCE OF, WITH POLYDACTYLY
188770 TIBIA, HYPOPLASIA OF, WITH POLYDACTYLY
188800 TIBIAL TORSION, BILATERAL MEDIAL
189150 TOE, ROTATED FIFTH
189230 TOES, SPACE BETWEEN FIRST AND SECOND
189300 TONGUE CURLING, FOLDING, OR ROLLING CLOVERLEAF TONGUE, INCLUDED
189490 MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA
189500 WITKOP SYNDROME
189600 TORTICOLLIS
189700 TORUS PALATINUS AND TORUS MANDIBULARIS
189800 PREECLAMPSIA/ECLAMPSIA 1; PEE1
189960 TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA
189961 TRACHEOPATHIA OSTEOPLASTICA
190100 GENIOSPASM 1; GSM1
190200 TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS
190300 TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
190310 TREMOR, NYSTAGMUS, AND DUODENAL ULCER
190320 TRICHODENTOOSSEOUS SYNDROME
190330 TRICHOMEGALY
190340 TRICHODISCOMAS, FAMILIAL MULTIPLE
190345 TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC
190350 TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1
190351 TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3
190360 TRICHODYSPLASIA-XERODERMA
190410 TRIGGER THUMB
190420 TRIGLYCERIDE STORAGE DISEASE, TYPE I
190430 TRIGLYCERIDE STORAGE DISEASE, TYPE II
190440 TRIGONOCEPHALY 1; TRIGNO1
190500 TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES
190600 TRIPHALANGEAL THUMB, NONOPPOSABLE
190650 TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA
190680 TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY
190685 DOWN SYNDROME TRISOMY 21, INCLUDED
190800 TRISTICHIASIS
190900 TRITANOPIA
191000 TROCHLEA OF THE HUMERUS, APLASIA OF
191100 TUBEROUS SCLEROSIS 1; TSC1
191150 TUFTSIN DEFICIENCY
191200 TUNE DEAFNESS
191390 INFLAMMATORY BOWEL DISEASE 11; IBD11
191400 ULNA AND FIBULA, HYPOPLASIA OF
191420 ULNA METAPHYSEAL DYSPLASIA SYNDROME
191440 ULNAR HYPOPLASIA
191480 UNCOMBABLE HAIR SYNDROME
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY
191500 UNDRITZ ANOMALY
191520 UPINGTON DISEASE
191540 URATE OXIDASE, PSEUDOGENE; UOX
191550 URETER, BIFID OR DOUBLE
191600 URETER, CANCER OF
191650 URETEROCELE
191700 UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT
191800 URINARY BLADDER, ATONY OF
191830 RENAL ADYSPLASIA
191850 URTICARIA, AQUAGENIC
191900 MUCKLE-WELLS SYNDROME; MWS
191950 URTICARIA, FAMILIAL LOCALIZED HEAT
192000 UTERINE ANOMALIES
192050 UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS
192100 UVULA, BIFID
192200 VARICOSE VEINS
192310 VASCULITIS, LYMPHOCYTIC, NODULAR
192315 VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL
192350 VATER ASSOCIATION VACTERL ASSOCIATION, INCLUDED
192430 VELOCARDIOFACIAL SYNDROME
192445 VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE
192500 LONG QT SYNDROME 1; LQT1
192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1
192605 VENTRICULAR TACHYCARDIA, FAMILIAL
192700 VENULAR INSUFFICIENCY, SYSTEMIC
192800 VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS
192900 VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS
192950 VERTICAL TALUS, CONGENITAL; CVT
193000 VESICOURETERAL REFLUX 1; VUR1
193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4
193005 VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE
193007 VERTIGO, BENIGN RECURRENT; BRV
193050 VIBRATORY ANGIOEDEMA
193090 TRANSCOBALAMIN I DEFICIENCY
193100 HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR
193200 VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6
193220 VITREORETINOCHOROIDOPATHY; VRCP
193230 VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD
193235 VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
193240 VOCAL CORD PARALYSIS AND PTOSIS
193250 VOLVULUS OF MIDGUT
193300 VON HIPPEL-LINDAU SYNDROME; VHL VON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED
193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1
193450 VULVOVAGINITIS, ALLERGIC SEMINAL
193500 WAARDENBURG SYNDROME, TYPE 1; WS1
193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A
193520 WATSON SYNDROME
193530 WEYERS ACROFACIAL DYSOSTOSIS
193670 WHIM SYNDROME
193680 WHISPERING DYSPHONIA, HEREDITARY
193700 ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A
193900 WHITE SPONGE NEVUS; WSN
194000 WIDOW'S PEAK
194050 WILLIAMS-BEUREN SYNDROME; WBS
194070 WILMS TUMOR 1; WT1
194071 WILMS TUMOR 2; WT2
194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR
194080 DENYS-DRASH SYNDROME; DDS
194090 WILMS TUMOR 3; WT3
194190 WOLF-HIRSCHHORN SYNDROME; WHS
194200 WOLFF-PARKINSON-WHITE SYNDROME
194300 WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH
194320 WORONETS TRAIT
194350 WT LIMB-BLOOD SYNDROME
194380 DEHYDRATED HEREDITARY STOMATOCYTOSIS; DHS
194400 XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD
200100 ABETALIPOPROTEINEMIA; ABL
200110 ABLEPHARON-MACROSTOMIA SYNDROME
200130 ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION
200150 CHOREOACANTHOCYTOSIS; CHAC
200170 ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT
200400 ACHALASIA, FAMILIAL ESOPHAGEAL
200450 ACHALASIA-MICROCEPHALY SYNDROME
200500 ACHEIROPODY
200600 ACHONDROGENESIS, TYPE IA; ACG1A
200610 ACHONDROGENESIS, TYPE II; ACG2
200700 CHONDRODYSPLASIA, GREBE TYPE
200900 SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY
200950 ACID PHOSPHATASE DEFICIENCY
200970 ACKERMAN SYNDROME
200980 ACRORENAL-MANDIBULAR SYNDROME
200990 ACROCALLOSAL SYNDROME; ACLS
200995 ACROCEPHALOPOLYDACTYLOUS DYSPLASIA
201000 CARPENTER SYNDROME
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV
201050 ACROCRANIOFACIAL DYSOSTOSIS
201100 ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
201170 ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ
201250 ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE
201300 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE
201400 ACTH DEFICIENCY, ISOLATED; IAD
201450 ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD
201470 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD
201475 ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD
201550 ADDUCTED THUMBS SYNDROME
201710 LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH
201750 ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202010 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
202150 ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE
202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1
202300 ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC ADRENOCORTICAL CARCINOMA, PEDIATRIC, INCLUDED
202355 ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT
202370 ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM
202400 AFIBRINOGENEMIA, CONGENITAL HYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED
202550 AGANGLIONOSIS, TOTAL INTESTINAL
202600 AGENESIS OF CEREBRAL WHITE MATTER
202650 AGNATHIA-OTOCEPHALY COMPLEX; AGOTC
202700 NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
202900 ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS
203000 FRONTONASAL DYSPLASIA WITH ALAR CLEFTS
203100 ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A
203200 ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2
203290 ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3
203300 HERMANSKY-PUDLAK SYNDROME 1; HPS1
203330 PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2
203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY
203450 ALEXANDER DISEASE
203500 ALKAPTONURIA
203550 ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN
203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1
203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC
203700 MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A
203740 ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY
203750 ALPHA-METHYLACETOACETIC ACIDURIA
203760 ALPHA-2-DEFICIENT COLLAGEN DISEASE
203780 ALPORT SYNDROME, AUTOSOMAL RECESSIVE
203800 ALSTROM SYNDROME; ALMS
204000 LEBER CONGENITAL AMAUROSIS 1; LCA1
204100 LEBER CONGENITAL AMAUROSIS 2; LCA2
204110 AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS
204200 CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
204300 CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A
204500 CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2
204650 AMELOGENESIS IMPERFECTA, TYPE IC; AI1C
204690 ENAMEL-RENAL SYNDROME; ERS
204700 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1
204730 AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS
204750 AMINOADIPIC ACIDURIA
204850 AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION
204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD
204900 AMYLOIDOSIS, CUTANEOUS BULLOUS
205000 AMYOTONIA CONGENITA
205100 AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
205200 AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA
205250 AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES
205400 TANGIER DISEASE; TGD
205700 ANEMIA, AUTOIMMUNE HEMOLYTIC
205950 ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE
206000 ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE
206100 ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD
206200 IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA
206300 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE
206400 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM
206500 ANENCEPHALY
206550 ANGIOLIPOMATOSIS, FAMILIAL
206570 ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT
206600 ANHIDROSIS
206700 ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION
206750 ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION
206780 ANODONTIA OF PERMANENT DENTITION
206800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4
206900 MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
206920 MICROPHTHALMIA WITH LIMB ANOMALIES
207000 ANOSMIA FOR ISOBUTYRIC ACID
207300 ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO
207410 ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2
207500 ANUS, IMPERFORATE
207600 TAKAYASU ARTERITIS
207620 APHALANGY WITH HEMIVERTEBRAE
207720 APNEA, CENTRAL SLEEP
207731 APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA
207740 APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED POLYNEUROPATHY
207750 APOLIPOPROTEIN C-II DEFICIENCY
207770 APROSENCEPHALY SYNDROME
207780 AREDYLD
207790 ARACHNOID CYSTS, INTRACRANIAL
207800 ARGININEMIA
207900 ARGININOSUCCINIC ACIDURIA
207950 CHIARI MALFORMATION TYPE II
208000 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1
208050 ARTERIAL TORTUOSITY SYNDROME; ATS
208060 ARTERIOSCLEROSIS, SEVERE JUVENILE
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION, AND FACIAL ANOMALIES
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC FACIES
208085 ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1
208100 ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN
208150 FETAL AKINESIA DEFORMATION SEQUENCE; FADS
208155 ILLUM SYNDROME
208200 ARTHROGRYPOSIS-LIKE DISORDER
208230 ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC
208250 CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP
208300 ASCITES, CHYLOUS
208400 ASPARTYLGLUCOSAMINURIA; AGU
208500 ASPHYXIATING THORACIC DYSTROPHY 1; ATD1
208530 ASPLENIA WITH CARDIOVASCULAR ANOMALIES
208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD
208550 ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE
208600 ASTHMA, SHORT STATURE, AND ELEVATED IgA
208700 ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA
208750 ATAXIA, DEAFNESS, AND CARDIOMYOPATHY
208850 ATAXIA-DEAFNESS-RETARDATION SYNDROME
208870 ATAXIA-MICROCEPHALY-CATARACT SYNDROME
208900 ATAXIA-TELANGIECTASIA; AT
208910 ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH
208920 ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH
209010 ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS, PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE
209050 ATHROMBIA, ESSENTIAL
209100 ATONIC-ASTATIC SYNDROME OF FOERSTER
209300 ATRANSFERRINEMIA
209500 ATRICHIA WITH PAPULAR LESIONS; APL
209600 ATRIOVENTRICULAR DISSOCIATION
209700 ATROPHODERMIA VERMICULATA
209770 AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION
209800 AUSTRALIA ANTIGEN
209850 AUTISM
209880 CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS
209900 BARDET-BIEDL SYNDROME; BBS BARDET-BIEDL SYNDROME 1, INCLUDED; BBS1, INCLUDED
209920 BARE LYMPHOCYTE SYNDROME, TYPE II
209950 ATYPICAL MYCOBACTERIOSIS, FAMILIAL
209970 BEEMER LETHAL MALFORMATION SYNDROME
210000 BEHR SYNDROME
210050 BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION
210100 BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF
210200 3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY
210210 3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY
210250 SITOSTEROLEMIA
210350 BIEMOND SYNDROME II
210370 BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY
210400 BIFID NOSE, AUTOSOMAL RECESSIVE
210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA
210550 BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY
210600 SECKEL SYNDROME 1; SCKL1
210700 MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE
210710 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1
210720 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2
210730 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III
210740 BANGSTAD SYNDROME
210745 BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE
210750 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6
210900 BLOOM SYNDROME; BLM
211000 BLUE DIAPER SYNDROME
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE
211170 BORRONE DERMATOCARDIOSKELETAL SYNDROME
211180 BOWEN-CONRADI SYNDROME; BWCNS
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS
211350 KYPHOMELIC DYSPLASIA
211369 BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY
211370 BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM
211380 BRACHIOSKELETOGENITAL SYNDROME
211390 SABINAS BRITTLE HAIR SYNDROME
211400 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1
211480 BUERGER DISEASE
211500 FAZIO-LONDE DISEASE
211530 BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1
211600 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1
211750 C SYNDROME
211770 CAHMR SYNDROME
211800 CALCIFICATION OF JOINTS AND ARTERIES; CALJA
211890 CAMPOMELIA, CUMMING TYPE
211900 TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1
211920 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA
211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES
211980 LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED
211990 CAMPTOMELIC SYNDROME, LONG-LIMB TYPE
212050 CANDIDIASIS, FAMILIAL, 2; CANDF2
212060 CARBIMAZOLE SENSITIVITY
212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
212066 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx
212070 CARBOXYPEPTIDASE N DEFICIENCY
212080 CARDIAC LIPIDOSIS, FAMILIAL
212090 CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA
212093 CARDIAC VALVULAR DEFECT, DEVELOPMENTAL
212100 CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS
212112 CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM
212130 CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE
212138 CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY
212140 CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
212160 CARNITINE DEFICIENCY, MYOPATHIC
212200 CARNOSINEMIA
212350 SENGERS SYNDROME
212360 PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL RECESSIVE
212400 CATARACT AND CONGENITAL ICHTHYOSIS
212500 CATARACT, CONGENITAL OR JUVENILE CATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME
212550 MICROPHTHALMIA, ISOLATED, WITH CATARACT 2; MCOPCT2
212710 CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME
212720 MARTSOLF SYNDROME
212750 CELIAC DISEASE; CD
212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS
212800 CEPHALIN LIPIDOSIS
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA
212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM
212850 CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS
212890 CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA
213000 CEREBELLAR HYPOPLASIA
213002 CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS
213010 CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME
213100 CEREBELLOPARENCHYMAL DISORDER II; CPD2
213200 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2
213300 JOUBERT SYNDROME; JBTS
213400 CEREBELLOPARENCHYMAL DISORDER V; CPD5
213600 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1
213700 CEREBROTENDINOUS XANTHOMATOSIS; CTX
213950 CEREBROCORTICAL DEGENERATION OF INFANCY
213980 CEREBROFACIOTHORACIC DYSPLASIA
214100 ZELLWEGER SYNDROME; ZS
214110 CEREBROHEPATORENAL SYNDROME, VARIANT TYPES
214150 CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1
214200 CEROID STORAGE DISEASE
214290 CERVICAL VERTEBRAE, AGENESIS OF
214300 KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2
214350 CHANDS
214370 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS
214400 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A
214450 GRISCELLI SYNDROME, TYPE 1; GS1
214500 CHEDIAK-HIGASHI SYNDROME; CHS
214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1
214800 CHARGE SYNDROME
214900 CHOLESTASIS-LYMPHEDEMA SYNDROME
214950 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4
214980 CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE
215030 CHOLESTEROL PNEUMONIA
215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD
215050 CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS
215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1
215140 HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA
215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED
215250 CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME
215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM
215450 CHOREA, BENIGN FAMILIAL
215470 CHORIORETINAL DYSTROPHY, SPINOCEREBELLAR ATAXIA, AND HYPOGONADOTROPIC HYPOGONADISM
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION
215500 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 1; CACD1
215510 CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY
215518 CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION
215520 CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES
215550 CIRCUMVALLATE PLACENTA SYNDROME
215600 CIRRHOSIS, FAMILIAL CIRRHOSIS, FAMILIAL, WITH PULMONARY HYPERTENSION, INCLUDED
215700 CITRULLINEMIA, CLASSIC
215720 CITRULLINE TRANSPORT DEFECT
215800 CLEFT LARYNX, POSTERIOR STRIDOR, CONGENITAL, INCLUDED
215850 CLEFT-LIMB-HEART MALFORMATION SYNDROME
216100 CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY
216300 CLEFT PALATE, DEAFNESS, AND OLIGODONTIA
216330 CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM
216340 CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA, ABSENT THUMBS, AND DISTAL APHALANGIA
216360 COACH SYNDROME
216400 COCKAYNE SYNDROME, TYPE A; CSA
216411 COCKAYNE SYNDROME, TYPE III
216550 COHEN SYNDROME; COH1
216700 COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC
216800 COLOBOMA OF MACULA AND SKELETAL ANOMALIES
216820 COLOBOMA, OCULAR
216900 ACHROMATOPSIA 2; ACHM2
216920 COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT
216950 COMPLEMENT COMPONENT C1r/C1s DEFICIENCY
217000 COMPLEMENT COMPONENT 2 DEFICIENCY; C2D
217080 JALILI SYNDROME
217085 CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY
217090 PLASMINOGEN DEFICIENCY, TYPE I LIGNEOUS CONJUNCTIVITIS, INCLUDED
217095 CONOTRUNCAL HEART MALFORMATIONS; CTHM TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED
217100 CONSTRICTING BANDS, CONGENITAL
217150 CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA
217200 CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET
217300 CORNEA PLANA 2; CNA2
217400 CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS
217500 CORNEAL DYSTROPHY, BAND-SHAPED
217520 CORNEAL DEGENERATION, BAND-SHAPED SPHEROID
217600 CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF
217700 CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE; CHED2
217800 MACULAR DYSTROPHY, CORNEAL, 1; MCDC1
217980 CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
217990 CORPUS CALLOSUM, AGENESIS OF
218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN
218010 CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY
218030 APPARENT MINERALOCORTICOID EXCESS; AME
218040 COSTELLO SYNDROME
218050 CRAMPS, FAMILIAL ADOLESCENT
218100 CRANIAL NERVES, CONGENITAL PARESIS OF
218200 CRANIAL NERVES, RECURRENT PARESIS OF
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD
218330 CRANIOECTODERMAL DYSPLASIA 1; CED1
218340 CRANIOFACIAL DYSMORPHISM WITH OCULAR COLOBOMA, ABSENT CORPUS CALLOSUM, AND AORTIC DILATATION
218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR
218450 CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS
218530 CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS
218550 CRANIOSYNOSTOSIS WITH FIBULAR APLASIA
218600 BALLER-GEROLD SYNDROME; BGS
218649 CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG
218650 CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME
218670 CRANIOTELENCEPHALIC DYSPLASIA
218700 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2
218800 CRIGLER-NAJJAR SYNDROME, TYPE I
218900 CROME SYNDROME
219000 FRASER SYNDROME
219050 CRYPTORCHIDISM, UNILATERAL OR BILATERAL
219070 CURVED NAIL OF FOURTH TOE
219080 ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
219090 PITUITARY ADENOMA, ACTH-SECRETING
219095 CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL
219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A
219150 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A
219200 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A
219250 CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC
219300 CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR
219400 CYANOSIS AND HEPATIC DISEASE
219500 CYSTATHIONINURIA
219550 CYSTEINE PEPTIDURIA
219600 CYSTIC DISEASE OF LUNG
219700 CYSTIC FIBROSIS; CF
219721 CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND SUBNORMAL MENTALITY
219730 VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE
219750 CYSTINOSIS, ADULT NONNEPHROPATHIC
219800 CYSTINOSIS, NEPHROPATHIC; CTNS
219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
220100 CYSTINURIA
220110 MITOCHONDRIAL COMPLEX IV DEFICIENCY
220111 LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC
220120 D-GLYCERIC ACIDURIA
220150 HYPOURICEMIA, RENAL, 1; RHUC1
220200 DANDY-WALKER SYNDROME; DWS DANDY-WALKER MALFORMATION, INCLUDED; DWM, INCLUDED
220210 DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT
220219 DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY
220220 DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY
220300 DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY
220400 JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1
220500 DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, AND MENTAL RETARDATION SYNDROME
220700 DEAFNESS, AUTOSOMAL RECESSIVE
220900 DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM
221200 DEAFNESS, COCHLEAR, WITH MYOPIA AND INTELLECTUAL IMPAIRMENT
221300 DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR
221320 DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES
221350 DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA
221400 DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY
221500 DEAFNESS, NEURAL, CONGENITAL MODERATE
221700 DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS
221740 DEAFNESS-OLIGODONTIA SYNDROME
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE
221750 PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
221760 DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF
221770 POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL
221780 DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH
221790 DERMATOLEUKODYSTROPHY
221800 DERMOCHONDROCORNEAL DYSTROPHY
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE
221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS
221900 RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC
221950 DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
222300 WOLFRAM SYNDROME 1; WFS1
222350 DIAMINOPENTANURIA
222400 DIAPHRAGMATIC HERNIA 2; DIH2
222448 DONNAI-BARROW SYNDROME
222470 TRICHOHEPATOENTERIC SYNDROME 1; THES1
222600 DIASTROPHIC DYSPLASIA
222690 DIBASIC AMINO ACIDURIA I
222700 LYSINURIC PROTEIN INTOLERANCE; LPI
222730 DICARBOXYLICAMINO ACIDURIA
222748 DIHYDROPYRIMIDINASE DEFICIENCY
222765 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2
222800 BISPHOSPHOGLYCERATE MUTASE DEFICIENCY
222900 SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID
223000 LACTASE DEFICIENCY, CONGENITAL
223100 LACTOSE INTOLERANCE, ADULT TYPE
223200 DISORGANIZATION, MOUSE, HOMOLOG OF
223320 DIVERTICULOSIS, SMALL-INTESTINAL
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT
223340 DK PHOCOMELIA SYNDROME
223350 DOHLE BODIES AND LEUKEMIA
223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL
223370 DUBOWITZ SYNDROME
223400 DUODENAL ATRESIA
223500 DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY
223550 DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION
223800 DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC
223900 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
224000 DYSAUTONOMIA-LIKE DISORDER
224050 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1
224100 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II; CDAN2
224120 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I; CDAN1
224230 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1; DKCB1
224250 DYSMYELINATION WITH JAUNDICE
224300 DYSOSTEOSCLEROSIS
224400 DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE
224410 DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH
224500 DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2
224550 DYSTONIA WITH RINGBINDEN
224690 MEIER-GORLIN SYNDROME 1; MGORS1
224700 EBSTEIN ANOMALY
224750 SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS
224800 ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS
224900 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE
225000 ROSSELLI-GULIENETTI SYNDROME
225040 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM
225050 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA
225060 CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1
225100 ECTOPIA LENTIS, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2
225200 ECTOPIA LENTIS ET PUPILLAE
225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5
225280 EEM SYNDROME
225290 ECTRODACTYLY-POLYDACTYLY
225300 SPLIT-HAND/FOOT MALFORMATION 6; SHFM6
225310 EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY
225320 EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM
225400 EHLERS-DANLOS SYNDROME, TYPE VI; EDS6
225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE
225450 ELLIPTOCYTOSIS, ATYPICAL
225500 ELLIS-VAN CREVELD SYNDROME; EVC
225700 ENCEPHALOMALACIA, MULTILOCULAR
225740 ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS
225750 AICARDI-GOUTIERES SYNDROME 1; AGS1
225753 PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4
225755 ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION
225790 PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH
226000 ENDOCARDIAL FIBROELASTOSIS; EFE
226100 ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA
226150 ENTEROCOLITIS
226200 ENTEROKINASE DEFICIENCY
226300 ENTEROPATHY, PROTEIN-LOSING
226350 EOSINOPHILIC FASCIITIS
226400 EPIDERMODYSPLASIA VERRUCIFORMIS; EV
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION
226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA
226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB
226650 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE
226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY
226700 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE
226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA
226735 EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA
226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS
226800 EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION
226850 EPILEPSY-TELANGIECTASIA
226900 EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
226950 EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS
226960 EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS
226980 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS
226990 EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY
227000 ERYTHEMA OF ACRAL REGIONS
227010 ERMINE PHENOTYPE
227050 TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC
227090 ERYTHRODERMA, LETHAL CONGENITAL
227150 ETHANOLAMINOSIS
227200 EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY
227220 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
227240 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION
227255 FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS
227260 SETLEIS SYNDROME
227270 FACIOCARDIOMELIC DYSPLASIA, LETHAL
227280 FACIOCARDIORENAL SYNDROME
227300 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1
227310 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN C AND PROTEIN C INHIBITOR
227320 FACIOTHORACOGENITAL SYNDROME
227330 FACIODIGITOGENITAL SYNDROME, RECESSIVE
227400 FACTOR V DEFICIENCY
227500 FACTOR VII DEFICIENCY
227600 FACTOR X DEFICIENCY
227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
227650 FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
227810 FANCONI-BICKEL SYNDROME; FBS
227850 FANCONI-LIKE SYNDROME
228000 FARBER LIPOGRANULOMATOSIS
228020 FASCIAL DYSTROPHY, CONGENITAL
228100 VISCERAL STEATOSIS, CONGENITAL
228250 FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
228300 FERTILE EUNUCH SYNDROME
228355 FETAL IODINE DEFICIENCY DISORDER; FIDD
228400 FEVER, FAMILIAL LIFELONG PERSISTENT
228520 FIBROCHONDROGENESIS 1; FBCG1
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES
228600 FIBROMATOSIS, JUVENILE HYALINE
228800 FIBROSCLEROSIS, MULTIFOCAL
228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY
228930 FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES
228960 HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY
228980 FLECK RETINA, FAMILIAL BENIGN; FRFB
228990 FLECK RETINA OF KANDORI
229045 FOCAL EPITHELIAL HYPERPLASIA, ORAL
229050 FOLATE MALABSORPTION, HEREDITARY
229070 FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED
229100 FORMIMINOTRANSFERASE DEFICIENCY
229120 FOUNTAIN SYNDROME
229200 BRITTLE CORNEA SYNDROME 1; BCS1
229230 FRASER-LIKE SYNDROME
229250 FREESIA FLOWERS, INABILITY TO SMELL
229300 FRIEDREICH ATAXIA 1; FRDA
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA
229400 FRONTOFACIONASAL DYSPLASIA
229500 FRUCTOSE AND GALACTOSE INTOLERANCE
229600 FRUCTOSE INTOLERANCE, HEREDITARY
229700 FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY
229850 FRYNS SYNDROME; FRNS
230000 FUCOSIDOSIS
230200 GALACTOKINASE DEFICIENCY
230300 GALACTORRHEA
230350 GALACTOSE EPIMERASE DEFICIENCY
230400 GALACTOSEMIA
230450 GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
230500 GM1-GANGLIOSIDOSIS, TYPE I
230600 GM1-GANGLIOSIDOSIS, TYPE II
230650 GM1-GANGLIOSIDOSIS, TYPE III
230740 GAPO SYNDROME
230750 GASTROSCHISIS ABDOMINAL WALL DEFECTS, INCLUDED
230800 GAUCHER DISEASE, TYPE I
230900 GAUCHER DISEASE, TYPE II
231000 GAUCHER DISEASE, TYPE III
231005 GAUCHER DISEASE, TYPE IIIC
231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1
231060 GENITOPALATOCARDIAC SYNDROME
231070 GERODERMA OSTEODYSPLASTICUM; GO
231080 GERMAN SYNDROME
231090 HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1
231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD
231100 HEMOCHROMATOSIS, NEONATAL
231200 BERNARD-SOULIER SYNDROME; BSS
231300 GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A
231530 3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS
231630 GLUTAMATE MONOSODIUM SENSITIVITY
231670 GLUTARIC ACIDEMIA I
231680 MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD
231690 GLUTARIC ACIDURIA III
231900 GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO
231950 GLUTATHIONURIA
231970 GLUTEAL MUSCLES, ABSENCE OF
232200 GLYCOGEN STORAGE DISEASE Ia
232220 GLYCOGEN STORAGE DISEASE Ib
232240 GLYCOGEN STORAGE DISEASE Ic
232300 GLYCOGEN STORAGE DISEASE II
232400 GLYCOGEN STORAGE DISEASE III
232500 GLYCOGEN STORAGE DISEASE IV
232600 GLYCOGEN STORAGE DISEASE V
232700 GLYCOGEN STORAGE DISEASE VI
232800 GLYCOGEN STORAGE DISEASE VII
232900 GLYCOPROTEIN STORAGE DISEASE
233100 RENAL GLUCOSURIA; GLYS1
233270 GOMBO SYNDROME
233300 OVARIAN DYSGENESIS 1; ODG1
233400 PERRAULT SYNDROME; PRLTS
233420 46,XY SEX REVERSAL 7; SRXY7
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES
233450 GOODPASTURE SYNDROME
233500 GORLIN-CHAUDHRY-MOSS SYNDROME
233600 GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY
233650 COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
233670 GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS
233690 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE
233700 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I
233710 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II
233800 GROUPED PIGMENTATION OF THE MACULA
233805 GROWTH FACTORS, COMBINED DEFECT OF
233810 GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA
233910 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B
234030 HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION
234050 TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1
234100 HALLERMANN-STREIFF SYNDROME; HSS
234200 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME
234280 HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY
234350 HALOTHANE HEPATITIS
234500 HARTNUP DISORDER
234580 HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS
234700 HEART BLOCK, CONGENITAL
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES
234810 HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY
234820 HEMANGIOPERICYTOMA, MALIGNANT
235000 HEMIHYPERPLASIA, ISOLATED; IH
235200 HEMOCHROMATOSIS; HFE
235255 MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY
235370 HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS
235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1
235500 HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN
235510 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME
235550 HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI
235555 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2
235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY
235730 MOWAT-WILSON SYNDROME
235740 HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS
235750 HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG TOES, AND VENTRICULAR SEPTAL DEFECT
235760 HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL FEATURES
235800 HISTIDINEMIA
235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT
235900 HISTIOCYTOSIS, FAMILIAL LIPOCHROME
236000 LYMPHOMA, HODGKIN
236100 HOLOPROSENCEPHALY
236110 HOLZGREVE SYNDROME
236130 HOMOCARNOSINOSIS
236200 HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY
236270 HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE
236300 HOOFT DISEASE
236400 HUMERORADIAL SYNOSTOSIS HUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME, INCLUDED
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME
236490 HYALINOSIS, INFANTILE SYSTEMIC
236500 HYDRANENCEPHALY WITH RENAL APLASIA-DYSPLASIA
236600 HYDROCEPHALUS
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS
236660 HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS
236670 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1
236680 HYDROLETHALUS SYNDROME 1; HLS1
236690 HYDROCEPHALUS, NORMAL-PRESSURE
236700 MCKUSICK-KAUFMAN SYNDROME; MKKS
236730 UROFACIAL SYNDROME; UFS
236750 HYDROPS FETALIS, NONIMMUNE; NIHF HYDROPS FETALIS, ALPHA-THALASSEMIA-RELATED, INCLUDED
236792 L-2-HYDROXYGLUTARIC ACIDURIA
236795 3-@HYDROXYISOBUTYRIC ACIDURIA
236800 HYDROXYKYNURENINURIA
236900 HYDROXYLYSINURIA
237000 HYDROXYPROLINEMIA
237100 HYMEN, IMPERFORATE
237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO
237310 N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY
237400 HYPER-BETA-ALANINEMIA
237450 HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
237500 DUBIN-JOHNSON SYNDROME; DJS
237550 HYPERBILIRUBINEMIA, CONJUGATED, TYPE III
237800 HYPERBILIRUBINEMIA, SHUNT
237900 HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN
238320 LEYDIG CELL HYPOPLASIA, TYPE I
238340 HYPERLEUCINE-ISOLEUCINEMIA
238350 HYPERLEXIA
238600 HYPERLIPOPROTEINEMIA, TYPE I
238700 HYPERLYSINEMIA
238710 HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA
238750 HYPERLYSINURIA WITH HYPERAMMONEMIA
238950 HYPEROPIA, HIGH
238970 HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME
239000 PAGET DISEASE, JUVENILE
239100 HYPEROSTOSIS CORTICALIS GENERALISATA
239199 HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA
239200 HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSHPT
239300 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1
239350 HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES
239400 HYPERPIPECOLATEMIA
239500 HYPERPROLINEMIA, TYPE I; HPI
239510 HYPERPROLINEMIA, TYPE II; HPII
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2
239711 HYPERTELORISM AND TETRALOGY OF FALLOT
239800 HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME
239840 HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY
239850 HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA
239900 HYPERTROPHIC NEUROPATHY AND CATARACT
240000 HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE
240150 HYPERVITAMINOSIS A, SUSCEPTIBILITY TO
240200 HYPOADRENOCORTICISM, FAMILIAL
240300 AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I; APS1
240500 IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2
240600 GLYCOGEN STORAGE DISEASE 0, LIVER
240800 HYPOGLYCEMIA, LEUCINE-INDUCED; LIH
240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH
240950 HYPOGONADISM-CATARACT SYNDROME
241000 HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY
241080 WOODHOUSE-SAKATI SYNDROME
241090 HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA
241100 HYPOGONADISM, MALE HYPOGONADISM AND TESTICULAR ATROPHY, INCLUDED
241120 HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES
241150 HYPOKALEMIA, FAMILIAL
241200 BARTTER SYNDROME, ANTENATAL, TYPE 2
241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS
241410 HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD
241500 HYPOPHOSPHATASIA, INFANTILE
241510 HYPOPHOSPHATASIA, CHILDHOOD
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS
241520 HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1
241530 HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH
241550 HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1
241600 HYPOPROTEINEMIA, HYPERCATABOLIC
241760 HYPOSPADIAS-MENTAL RETARDATION SYNDROME
241800 HYPOTHALAMIC HAMARTOMAS CONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED
241850 HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
242050 HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY
242100 ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1; NCIE1
242150 ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS
242300 ICHTHYOSIS, LAMELLAR, 1; LI1
242500 ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE
242510 ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION
242520 ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION
242530 ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT
242550 ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA
242600 IMINOGLYCINURIA
242670 CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA
242700 IMMUNE DEFECT DUE TO ABSENCE OF THYMUS
242840 IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM
242850 IMMUNE DEFICIENCY DISEASE
242860 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1
242870 IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTS AND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES
242880 IMMUNOERYTHROMYELOID HYPOPLASIA
242890 IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW
242900 IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
243000 INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE
243050 INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION
243060 SPERMATOGENIC FAILURE 5; SPGF5
243080 INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO
243100 INTERNAL CAROTID ARTERIES, HYPOPLASIA OF
243110 IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1
243150 INTESTINAL ATRESIA, MULTIPLE
243180 VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE
243200 INTRACRANIAL HYPERTENSION, IDIOPATHIC
243300 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1
243310 BARAITSER-WINTER SYNDROME 1; BRWS1
243320 INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME
243450 ISOVALERIC ACID, INABILITY TO SMELL
243500 ISOVALERIC ACIDEMIA; IVA
243600 JEJUNAL ATRESIA
243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
243800 JOHANSON-BLIZZARD SYNDROME; JBS
243910 ARIMA SYNDROME
244200 KALLMANN SYNDROME 3; KAL3
244300 KAPUR-TORIELLO SYNDROME
244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1
244450 KAUFMAN OCULOCEREBROFACIAL SYNDROME
244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1
244600 KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC KPC WITH ASSOCIATED MALFORMATIONS, INCLUDED
244850 KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE
245000 PAPILLON-LEFEVRE SYNDROME; PALS
245010 HAIM-MUNK SYNDROME; HMS
245050 SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY
245100 KETOACIDURIA WITH MENTAL DEFICIENCY AND OTHER FEATURES
245130 KETOADIPICACIDURIA
245150 KEUTEL SYNDROME
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS
245180 KIFAFA SEIZURE DISORDER
245190 KNIEST-LIKE DYSPLASIA, LETHAL
245200 KRABBE DISEASE
245300 KURU, SUSCEPTIBILITY TO
245340 ERYTHROCYTE LACTATE TRANSPORTER DEFECT
245348 PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD
245349 PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD
245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9
245450 LACTIC ACIDURIA DUE TO D-LACTIC ACID
245480 SPECIFIC GRANULE DEFICIENCY; SGD
245550 LAMBERT SYNDROME
245552 LAMBOTTE SYNDROME
245570 LANDAU-KLEFFNER SYNDROME; LKS
245600 MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE
245660 LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS
245800 LAURENCE-MOON SYNDROME
245900 LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY
246000 LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT
246200 DONOHUE SYNDROME
246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3
246400 LETTERER-SIWE DISEASE
246450 3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD
246470 LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER
246500 LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS
246550 LICHTENSTEIN SYNDROME
246555 LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY
246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
246570 FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME
246700 CHYLOMICRON RETENTION DISEASE; CMRD
247100 LIPOID PROTEINOSIS OF URBACH AND WIETHE
247200 MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
247410 LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME
247420 LUTHERAN NULL
247430 LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF
247440 LYMPHEDEMA, CONGENITAL RECESSIVE
247450 LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN
247610 LYMPHOID INTERSTITIAL PNEUMONIA; LIP
247630 LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE
247640 LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL
247650 LYMPHOKINE DEFICIENCY
247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS
247950 LYSINE MALABSORPTION SYNDROME
247990 MACDERMOT-WINTER SYNDROME
248000 MACROCEPHALY
248010 MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE
248100 MACROSOMIA ADIPOSA CONGENITA
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL
248190 HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5
248200 STARGARDT DISEASE 1; STGD1
248250 HYPOMAGNESEMIA 3, RENAL; HOMG3
248300 MAL DE MELEDA
248340 3MC SYNDROME 3; 3MC3
248360 MALONYL-CoA DECARBOXYLASE DEFICIENCY
248370 MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA
248390 TREACHER COLLINS SYNDROME 3; TCS3
248400 MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL DEFICIENCY
248450 MANITOBA OCULOTRICHOANAL SYNDROME; MOTA
248500 MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA
248510 MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB
248600 MAPLE SYRUP URINE DISEASE
248700 MARDEN-WALKER SYNDROME
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS
248770 MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL
248800 MARINESCO-SJOGREN SYNDROME; MSS
248900 MAST SYNDROME
248910 CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA
248950 MCDONOUGH SYNDROME
249000 MECKEL SYNDROME, TYPE 1; MKS1
249100 FAMILIAL MEDITERRANEAN FEVER; FMF
249210 MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME
249230 MEGAEPIPHYSEAL DWARFISM
249240 MEGALENCEPHALY WITH DYSMYELINATION
249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA
249310 MEGALOCORNEA-MENTAL RETARDATION SYNDROME
249400 MELANOSIS, NEUROCUTANEOUS
249420 FRANK-TER HAAR SYNDROME; FTHS
249500 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1
249599 MENTAL RETARDATION SYNDROME, BELGIAN TYPE
249600 MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
249620 OHDO SYNDROME
249630 MENTAL RETARDATION, BUENOS AIRES TYPE
249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU
249660 MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES
249670 MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION
249700 LANGER MESOMELIC DYSPLASIA; LMD
249710 MESOMELIC LIMB SHORTENING AND BOWING
249900 METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
250100 METACHROMATIC LEUKODYSTROPHY
250215 METAPHYSEAL ACROSCYPHODYSPLASIA
250220 SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE
250250 CARTILAGE-HAIR HYPOPLASIA; CHH
250300 METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE
250400 METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE
250410 METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA
250420 METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS
250450 METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY
250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS
250500 METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA
250620 BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY
250650 METHANE PRODUCTION
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY
250790 METHEMOGLOBINEMIA TYPE IV
250800 METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE
250850 METHIONINE ADENOSYLTRANSFERASE DEFICIENCY
250900 METHIONINE MALABSORPTION SYNDROME
250940 METHYLCOBALAMIN DEFICIENCY, cblG TYPE
250950 3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1
250951 3-@METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4
251000 METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY
251100 METHYLMALONIC ACIDURIA, cblA TYPE
251110 METHYLMALONIC ACIDURIA, cblB TYPE
251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE
251200 MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1
251220 MICROCEPHALY-CARDIOMYOPATHY
251230 MICROCEPHALY-MICROMELIA SYNDROME
251240 MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA
251250 MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES
251255 JAWAD SYNDROME; JWDS
251260 NIJMEGEN BREAKAGE SYNDROME
251270 MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION, AUTOSOMAL RECESSIVE
251280 MICROCEPHALY WITH SPASTIC QUADRIPLEGIA
251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG
251300 MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME
251400 MICROCOLON
251450 DESBUQUOIS DYSPLASIA; DBQD
251505 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4
251600 MICROPHTHALMIA, ISOLATED 1; MCOP1
251700 MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES
251800 MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS
251850 DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2
251880 MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3
251900 MITOCHONDRIAL MYOPATHY
251945 MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT
251950 MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS
252010 MITOCHONDRIAL COMPLEX I DEFICIENCY
252011 MITOCHONDRIAL COMPLEX II DEFICIENCY
252100 MOHR SYNDROME
252150 MOLYBDENUM COFACTOR DEFICIENCY
252250 MONOCYTE CHEMOTACTIC DISORDER
252270 MONOSOMY 7 OF BONE MARROW
252300 MORQUIO SYNDROME C
252320 MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA
252350 MOYAMOYA DISEASE 1; MYMY1
252500 MUCOLIPIDOSIS II ALPHA/BETA
252600 MUCOLIPIDOSIS III ALPHA/BETA
252605 MUCOLIPIDOSIS III GAMMA
252650 MUCOLIPIDOSIS IV
252700 MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES
252900 MUCOPOLYSACCHARIDOSIS TYPE IIIA
252920 MUCOPOLYSACCHARIDOSIS TYPE IIIB
252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC
252940 MUCOPOLYSACCHARIDOSIS TYPE IIID
253000 MUCOPOLYSACCHARIDOSIS TYPE IVA
253010 MUCOPOLYSACCHARIDOSIS TYPE IVB
253200 MUCOPOLYSACCHARIDOSIS TYPE VI
253220 MUCOPOLYSACCHARIDOSIS TYPE VII
253240 MUCUS INSPISSATION OF RESPIRATORY TRACT
253250 MULIBREY NANISM
253260 BIOTINIDASE DEFICIENCY MULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET
253270 HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
253280 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3
253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS
253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1
253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM
253400 SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
253550 SPINAL MUSCULAR ATROPHY, TYPE II; SMA2
253590 MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY
253600 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A
253601 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B
253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C
253800 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4
253900 MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS
254000 MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM
254090 ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD
254100 MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION
254110 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H
254120 MUSCULAR HYPERTONIA, LETHAL
254130 MIYOSHI MUSCULAR DYSTROPHY 1; MMD1
254150 MUSK, INABILITY TO SMELL
254190 MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS
254200 MYASTHENIA GRAVIS; MG
254210 MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA
254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL
254400 MYCOSIS FUNGOIDES
254450 MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
254600 MYELOPEROXIDASE DEFICIENCY; MPOD
254700 MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE
254770 EPILEPSY, MYOCLONIC JUVENILE; EJM
254780 MYOCLONIC EPILEPSY OF LAFORA
254800 MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
254900 EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE; EPM4
254940 MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN SEQUENCE
254950 MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA
254960 MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT
255100 MYOPATHY WITH ABNORMAL LIPID METABOLISM
255110 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET
255120 CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY
255125 MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML
255140 MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA
255160 MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE
255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2
255300 MYOPATHY, CONGENITAL
255310 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD
255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA
255500 MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18
255600 MYOSCLEROSIS, AUTOSOMAL RECESSIVE
255700 MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE
255710 MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION
255800 SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
255900 MYXEDEMA
255960 MYXOMA, INTRACARDIAC
255980 NASODIGITOACOUSTIC SYNDROME
255990 NATHALIE SYNDROME
255995 NATIVE AMERICAN MYOPATHY; NAM
256000 LEIGH SYNDROME; LS
256020 NAIL-PATELLA-LIKE RENAL DISEASE
256030 NEMALINE MYOPATHY 2; NEM2
256040 AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD
256050 ATELOSTEOGENESIS, TYPE II; AOII
256100 NEPHRONOPHTHISIS 1; NPHP1
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM
256150 NEPHROSIALIDOSIS
256200 NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS
256300 NEPHROTIC SYNDROME, TYPE 1; NPHS1
256370 NEPHROTIC SYNDROME, TYPE 4; NPHS4
256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1
256500 NETHERTON SYNDROME; NETH
256520 NEU-LAXOVA SYNDROME; NLS
256540 GALACTOSIALIDOSIS; GSL
256550 NEURAMINIDASE DEFICIENCY
256600 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A
256690 NEUROFACIODIGITORENAL SYNDROME
256700 NEUROBLASTOMA, SUSCEPTIBILITY TO NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NBLST1, INCLUDED
256710 ELEJALDE DISEASE
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY
256730 CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1
256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5
256800 INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA
256810 MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6
256840 NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE
256850 GIANT AXONAL NEUROPATHY 1; GAN1
256860 NEUROPATHY, HEREDITARY SENSORY, ATYPICAL
256870 NEUROPATHY, PAINFUL
257100 NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA
257150 NEUTROPHIL ACTIN DYSFUNCTION; NAD
257200 NIEMANN-PICK DISEASE, TYPE A
257220 NIEMANN-PICK DISEASE, TYPE C1; NPC1
257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1
257320 LISSENCEPHALY 2; LIS2
257350 NUCHAL BLEB, FAMILIAL
257400 NYSTAGMUS, CONGENITAL, AUTOSOMAL RECESSIVE
257500 OBESITY-HYPOVENTILATION SYNDROME
257550 OCULAR MOTOR APRAXIA
257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY
257790 OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS
257800 OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION
257850 OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
257910 OCULOPALATOCEREBRAL SYNDROME
257920 3MC SYNDROME 1; 3MC1
257960 OCULOTRICHODYSPLASIA; OTD
257970 OCULORENOCEREBELLAR SYNDROME
257980 ODONTOONYCHODERMAL DYSPLASIA; OODD
258040 OEIS COMPLEX
258100 OGUCHI DISEASE 1
258150 SPERMATOGENIC FAILURE 1; SPGF1
258200 OLIVER SYNDROME
258300 OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE
258315 OMODYSPLASIA 1; OMOD1
258320 OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL
258360 ONYCHOTRICHODYSPLASIA AND NEUTROPENIA
258400 OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS
258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE; PEOB
258470 OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA
258480 OPSISMODYSPLASIA
258500 OPTIC ATROPHY 6; OPA6
258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE
258660 NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO
258700 OPTICOCOCHLEODENTATE DEGENERATION
258800 ORAL SENSIBILITY, DISTURBANCE OF
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS
258850 OROFACIODIGITAL SYNDROME III; OFD3
258860 OROFACIODIGITAL SYNDROME IV; OFD4
258865 OROFACIODIGITAL SYNDROME IX; OFD9
258870 GYRATE ATROPHY OF CHOROID AND RETINA; GACR
258900 OROTIC ACIDURIA
259050 OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES
259100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1
259200 BLOUNT DISEASE, ADOLESCENT
259270 OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI
259410 OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS
259420 OSTEOGENESIS IMPERFECTA, TYPE III
259440 OSTEOGENESIS IMPERFECTA, TYPE IX
259450 BRUCK SYNDROME 1; BRKS1
259500 OSTEOGENIC SARCOMA
259600 TORG-WINCHESTER SYNDROME
259610 OSTEOLYSIS SYNDROME, RECESSIVE
259650 OSTEOMA OF MIDDLE EAR
259660 OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION
259680 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO
259690 OSTEOPENIA AND SPARSE HAIR
259700 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1
259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2
259720 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5
259730 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3
259750 OSTEOPOROSIS, JUVENILE
259770 OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
259775 RAINE SYNDROME; RNS
259780 OTOONYCHOPERONEAL SYNDROME
259900 HYPEROXALURIA, PRIMARY, TYPE I; HP1
260000 HYPEROXALURIA, PRIMARY, TYPE II
260005 5-@OXOPROLINASE DEFICIENCY; OPLAHD
260100 PA POLYMORPHISM OF ALPHA-2-GLOBULIN
260130 PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE
260150 PALANT CLEFT PALATE SYNDROME
260200 PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA
260300 PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15
260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN
260400 SHWACHMAN-DIAMOND SYNDROME; SDS
260450 PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE
260470 PANENCEPHALITIS, SUBACUTE SCLEROSING
260480 PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX
260500 PAPILLOMA OF CHOROID PLEXUS
260530 PARANA HARD-SKIN SYNDROME
260540 PARKINSON-DEMENTIA SYNDROME SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED
260565 PEHO SYNDROME
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN
260600 LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3
260650 PELLAGRA-LIKE SYNDROME
260660 COUSIN SYNDROME
260800 PENTOSURIA
260900 PERICARDIAL EFFUSION, CHRONIC
260910 PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL
260920 HYPER-IgD SYNDROME; HIDS
260950 PERIODONTITIS, CHRONIC
260970 PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN
261000 INTRINSIC FACTOR DEFICIENCY; IFD
261100 MEGALOBLASTIC ANEMIA 1
261400 PERONEUS TERTIUS MUSCLE, ABSENCE OF
261515 D-BIFUNCTIONAL PROTEIN DEFICIENCY
261540 PETERS-PLUS SYNDROME
261550 PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
261560 PFEIFFER-PALM-TELLER SYNDROME
261590 PHENFORMIN 4-HYDROXYLATION
261600 PHENYLKETONURIA; PKU
261630 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C
261640 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A
261650 PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL
261670 GLYCOGEN STORAGE DISEASE X; GSD10
261680 PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC
261740 GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
261750 GLYCOGEN STORAGE DISEASE IXb; GSD9B
261800 PIERRE ROBIN SYNDROME
261900 PILI TORTI, EARLY-ONSET
262000 BJORNSTAD SYNDROME; BJS
262020 PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS
262190 PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES
262300 ACHROMATOPSIA 3; ACHM3
262400 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A
262500 LARON SYNDROME
262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2
262650 KOWARSKI SYNDROME
262700 PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4
262710 PITUITARY DWARFISM WITH LARGE SELLA TURCICA
262800 PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF
262850 ALPHA-2-PLASMIN INHIBITOR DEFICIENCY
262875 PLATELET PROSTACYCLIN RECEPTOR DEFECT
262900 PLEOCONIAL MYOPATHY WITH SALT CRAVING
263000 INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP
263100 POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS
263200 POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA
263300 POLYCYTHEMIA VERA
263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2
263450 POLYDACTYLY, POSTAXIAL
263510 SHORT RIB-POLYDACTYLY SYNDROME, TYPE III
263520 SHORT RIB-POLYDACTYLY SYNDROME, TYPE II
263530 SHORT RIB-POLYDACTYLY SYNDROME, TYPE I; SRPS1
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES
263550 POLYMYOCLONUS, INFANTILE
263570 POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD
263610 POLYHYDRAMNIOS, CHRONIC IDIOPATHIC
263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION
263650 POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE
263700 PORPHYRIA, CONGENITAL ERYTHROPOIETIC
263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS
263800 GITELMAN SYNDROME
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY
264050 PRENATAL BOWING
264060 PREPAPILLARY VASCULAR LOOPS
264070 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D
264080 PROGESTERONE RESISTANCE
264090 PROGEROID SYNDROME, NEONATAL
264110 PROLACTIN DEFICIENCY, ISOLATED
264120 PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES
264140 PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS
264180 PSEUDODIASTROPHIC DYSPLASIA
264270 PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES
264300 17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY
264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B
264420 FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM
264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES
264480 PSEUDOTRISOMY 13 SYNDROME
264500 PSEUDOURIDINURIA AND MENTAL DEFECT
264600 PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH
264700 VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A
264800 PSEUDOXANTHOMA ELASTICUM; PXE
265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS
265050 3MC SYNDROME 2; 3MC2
265100 PULMONARY ALVEOLAR MICROLITHIASIS
265120 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1
265140 PULMONARY ARTERIOVENOUS FISTULAS
265150 PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM
265200 PULMONARY BULLAE CAUSING PNEUMOTHORAX
265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL
265380 ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE
265430 LUNG AGENESIS
265450 PULMONARY VENOOCCLUSIVE DISEASE; PVOD
265500 PULMONIC STENOSIS
265800 PYCNODYSOSTOSIS
265850 PYGMY
265880 PYKNOACHONDROGENESIS
265900 PYLE DISEASE
265950 PYLORIC ATRESIA
266100 EPILEPSY, PYRIDOXINE-DEPENDENT; EPD
266120 URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
266130 GLUTATHIONE SYNTHETASE DEFICIENCY
266140 PYROPOIKILOCYTOSIS, HEREDITARY; HPP
266150 PYRUVATE CARBOXYLASE DEFICIENCY
266200 PYRUVATE KINASE DEFICIENCY OF RED CELLS
266250 RADICULONEUROPATHY, FATAL NEONATAL
266255 RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA
266265 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C
266270 RAMON SYNDROME
266280 RAPADILINO SYNDROME
266300 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2
266350 RED SKIN PIGMENT ANOMALY OF NEW GUINEA
266400 REESE RETINAL DYSPLASIA
266500 REFSUM DISEASE, ADULT
266510 REFSUM DISEASE, INFANTILE
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1 REGIONAL ENTERITIS, INCLUDED
266810 RENAL AND MULLERIAN DUCT HYPOPLASIA
266900 SENIOR-LOKEN SYNDROME 1; SLSN1
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME
266920 MAINZER-SALDINO SYNDROME; MZSDS
267000 PERLMAN SYNDROME; PRLMNS
267200 RENAL TUBULAR ACIDOSIS III
267300 RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
267400 RENAL, GENITAL, AND MIDDLE EAR ANOMALIES
267430 RENAL TUBULAR DYSGENESIS; RTD
267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
267480 RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA
267500 RETICULAR DYSGENESIS
267700 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1
267730 RETICULUM CELL SARCOMA
267740 RETINAL DEGENERATION AND EPILEPSY
267750 KNOBLOCH SYNDROME 1; KNO1
267760 RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA
267800 RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE
267900 RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA
268000 RETINITIS PIGMENTOSA; RP
268010 RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS
268020 RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM
268025 RETINITIS PIGMENTOSA, LATE-ADULT ONSET
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME
268050 RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION
268060 RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE
268080 RETINOSCHISIS OF FOVEA
268100 ENHANCED S-CONE SYNDROME; ESCS GOLDMANN-FAVRE SYNDROME, INCLUDED
268130 REVESZ SYNDROME
268150 RH-NULL, REGULATOR TYPE; RHN RH DEFICIENCY SYNDROME, INCLUDED
268200 MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE
268210 RHABDOMYOSARCOMA 1; RMS1
268220 RHABDOMYOSARCOMA 2; RMS2
268240 RHEUMATIC FEVER-RELATED ANTIGEN RHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED
268250 RHIZOMELIC SYNDROME
268300 ROBERTS SYNDROME; RBS
268305 ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES
268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS
268320 RODRIGUES BLINDNESS
268400 ROTHMUND-THOMSON SYNDROME; RTS
268500 ROWLEY-ROSENBERG SYNDROME
268650 RUDIGER SYNDROME
268700 SACCHAROPINURIA
268800 SANDHOFF DISEASE
268850 SAO PAULO MCA/MR SYNDROME
268900 SARCOSINEMIA
269000 SC PHOCOMELIA SYNDROME
269150 SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME
269200 AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2
269250 SCHNECKENBECKEN DYSPLASIA
269300 SCHWARTZ-LELEK SYNDROME
269400 SCLEROCORNEA, AUTOSOMAL RECESSIVE
269500 SCLEROSTEOSIS 1; SOST1
269600 SEA-BLUE HISTIOCYTE DISEASE
269630 SECOND METATARSAL-METACARPAL SYNDROME
269650 SECRETORY COMPONENT DEFICIENCY
269700 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE
269840 SEVERE COMBINED IMMUNODEFICIENCY, ATYPICAL
269860 SHORT RIB-POLYDACTYLY SYNDROME, TYPE IV
269870 SHORT STATURE-OBESITY SYNDROME; SSOS
269880 SHORT SYNDROME
269920 INFANTILE SIALIC ACID STORAGE DISORDER
269921 SIALURIA
270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5
270150 SJOGREN SYNDROME
270200 SJOGREN-LARSSON SYNDROME; SLS
270220 SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT
270300 PEELING SKIN SYNDROME
270350 SKUNK N-BUTYLMERCAPTAN, INABILITY TO SMELL
270400 SMITH-LEMLI-OPITZ SYNDROME; SLOS
270420 DIARRHEA 3, SECRETORY SODIUM, CONGENITAL; DIAR3
270450 INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO
270460 SONODA SYNDROME
270500 ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION
270550 SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS
270600 SPASTIC DIPLEGIA, INFANTILE TYPE
270685 SPASTIC PARAPLEGIA 17; SPG17
270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15
270710 FITZSIMMONS-GUILBERT SYNDROME
270750 SPASTIC PARAPLEGIA 23; SPG23
270800 SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A
270850 SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION
270950 SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION
270960 SPERMATOGENIC FAILURE 4; SPGF4
270970 SPHEROCYTOSIS, TYPE 3; SPH3
271109 SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION
271110 SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY
271150 SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4
271200 SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE
271220 SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL
271225 SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES
271245 MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7
271250 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3
271270 SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM
271310 SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY
271320 SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM
271400 SPLENIC HYPOPLASIA
271500 SPLENOPORTAL VASCULAR ANOMALIES
271510 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE
271520 SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES
271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE
271550 SPONDYLOENCHONDRODYSPLASIA; SPENCD
271600 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE
271620 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION
271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE
271640 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1; SEMDJL1
271650 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT
271665 SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE
271700 SPONDYLOPERIPHERAL DYSPLASIA
271900 CANAVAN DISEASE
271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI
271950 SUBAORTIC STENOSIS, MEMBRANOUS
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME
271980 SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY
272000 SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION
272100 SUDANOPHILIC CEREBRAL SCLEROSIS
272120 SUDDEN INFANT DEATH SYNDROME
272150 SUGARMAN BRACHYDACTYLY
272200 MULTIPLE SULFATASE DEFICIENCY; MSD
272300 SULFOCYSTEINURIA
272350 SUMMITT SYNDROME
272370 SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1
272430 COLD-INDUCED SWEATING SYNDROME 1; CISS1
272440 SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION
272450 SYNDESMODYSPLASIC DWARFISM
272460 SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT
272600 TAPETORETINAL DEGENERATION WITH ATAXIA
272650 TATSUMI FACTOR DEFICIENCY
272700 TAURODONTISM
272750 GM2-GANGLIOSIDOSIS, AB VARIANT
272800 TAY-SACHS DISEASE; TSD
272980 TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR
273000 TEETH, FUSED
273050 TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM
273120 TERATOMA, PINEAL
273150 TESTES, RUDIMENTARY
273250 TESTICULAR REGRESSION SYNDROME; TRS
273300 TESTICULAR GERM CELL TUMOR; TGCT
273390 TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES
273395 TETRAAMELIA, AUTOSOMAL RECESSIVE
273400 TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES
273600 THALIDOMIDE SUSCEPTIBILITY
273680 THANATOPHORIC DYSPLASIA, GLASGOW VARIANT
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME
273740 THORACOMELIC DYSPLASIA
273750 THREE M SYNDROME 1; 3M1
273770 THREONINEMIA
273800 GLANZMANN THROMBASTHENIA; GT
273900 THROMBOCYTOPENIA 3; THC3
274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR
274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP
274190 THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY
274200 THUMB, DISTAL HYPEREXTENSIBILITY OF
274205 THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS
274210 THYMIC APLASIA WITH FETAL DEATH
274230 THYMOMA, FAMILIAL
274240 THYROCEREBRORETINAL SYNDROME
274265 THYMIC-RENAL-ANAL-LUNG DYSPLASIA
274270 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
274300 THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH
274400 THYROID DYSHORMONOGENESIS 1; TDH1
274500 THYROID DYSHORMONOGENESIS 2A; TDH2A
274600 PENDRED SYNDROME; PDS
274700 THYROID DYSHORMONOGENESIS 3; TDH3
274800 THYROID DYSHORMONOGENESIS 4; TDH4
274900 THYROID DYSHORMONOGENESIS 5; TDH5
275000 GRAVES DISEASE
275100 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4
275120 THYROTROPIN-RELEASING HORMONE DEFICIENCY
275190 TIGLIC ACIDEMIA
275200 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1
275210 RESTRICTIVE DERMOPATHY, LETHAL
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS
275240 TINEA IMBRICATA, SUSCEPTIBILITY TO
275250 TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF
275300 TRACHEOBRONCHOMEGALY
275350 TRANSCOBALAMIN II DEFICIENCY
275355 SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
275370 TRICARBOXYLIC ACID CYCLE, DEFECT OF
275400 TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION OF RETINA
275450 TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY
275550 TRICHORRHEXIS NODOSA SYNDROME
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET
275630 CHANARIN-DORFMAN SYNDROME; CDS
275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20
276100 TRYPTOPHANURIA WITH DWARFISM
276200 T-SUBSTANCE ANOMALY
276300 MISMATCH REPAIR CANCER SYNDROME
276600 TYROSINEMIA, TYPE II
276700 TYROSINEMIA, TYPE I
276710 TYROSINEMIA, TYPE III
276800 TYROSINOSIS
276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY
276821 ULNAR HYPOPLASIA WITH MENTAL RETARDATION
276822 ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS
276880 UROCANASE DEFICIENCY
276900 USHER SYNDROME, TYPE I; USH1
276901 USHER SYNDROME, TYPE IIA; USH2A
276902 USHER SYNDROME, TYPE IIIA; USH3A
276904 USHER SYNDROME, TYPE IC; USH1C
276950 VACTERL ASSOCIATION WITH HYDROCEPHALUS
277000 MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME
277100 VALINEMIA
277150 VAN BOGAERT-HOZAY SYNDROME
277170 OROFACIODIGITAL SYNDROME VI; OFD6
277175 VASCULAR HYALINOSIS
277180 VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
277200 RIGHT VENTRICULAR HYPOPLASIA, ISOLATED
277300 SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1
277320 VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA
277350 HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE
277380 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE
277400 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
277410 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
277440 VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A
277450 VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1
277460 VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION
277470 PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A
277480 VON WILLEBRAND DISEASE, TYPE 3; VWD3
277580 WAARDENBURG SYNDROME, TYPE 4A; WS4A
277590 WEAVER SYNDROME 1; WVS1
277600 WEILL-MARCHESANI SYNDROME 1; WMS1
277610 WEISSENBACHER-ZWEYMULLER SYNDROME; WZS
277700 WERNER SYNDROME; WRN
277720 WHISTLING FACE SYNDROME, RECESSIVE FORM
277730 WERNICKE-KORSAKOFF SYNDROME
277740 WHITE FORELOCK WITH MALFORMATIONS
277900 WILSON DISEASE
277970 WISKOTT-ALDRICH SYNDROME
278000 LYSOSOMAL ACID LIPASE DEFICIENCY
278100 WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS
278150 HYPOTRICHOSIS 8; HYPT8
278200 WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS
278250 WRINKLY SKIN SYNDROME; WSS
278300 XANTHINURIA, TYPE I
278700 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
278720 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
278730 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
278740 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
278750 XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV
278760 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF
278780 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
278800 DE SANCTIS-CACCHIONE SYNDROME
278850 46,XX SEX REVERSAL 2; SRXX2
278900 XYLOSIDASE DEFICIENCY
279000 YOUNG SYNDROME
280000 COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME
300000 OPITZ GBBB SYNDROME, X-LINKED
300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA
300009 DENT DISEASE 1
300018 46,XY SEX REVERSAL 2; SRXY2
300030 DEAFNESS, X-LINKED 3; DFNX3
300042 ALOPECIA, CONGENITAL
300046 MENTAL RETARDATION, X-LINKED 23; MRX23
300047 MENTAL RETARDATION, X-LINKED 20; MRX20
300048 INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED
300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT
300055 MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13 MENTAL RETARDATION, X-LINKED 79; MRX79
300062 MENTAL RETARDATION, X-LINKED 14; MRX14
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM
300066 DEAFNESS, X-LINKED 4; DFNX4
300067 LISSENCEPHALY, X-LINKED, 1; LISX1
300068 ANDROGEN INSENSITIVITY SYNDROME; AIS
300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
300073 FETAL AKINESIA SYNDROME, X-LINKED
300076 IMMUNONEUROLOGIC DISORDER, X-LINKED
300085 CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300088 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9
300100 ADRENOLEUKODYSTROPHY; ALD
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED
300125 MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2
300143 MENTAL RETARDATION, X-LINKED 21; MRX21
300166 MICROPHTHALMIA, SYNDROMIC 2; MCOPS2
300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC
300209 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2
300215 LISSENCEPHALY, X-LINKED, 2; LISX2
300220 MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION
300238 MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11
300240 HOYERAAL-HREIDARSSON SYNDROME; HHS
300243 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH
300245 PTOSIS, HEREDITARY CONGENITAL 2
300257 DANON DISEASE
300258 ROIFMAN SYNDROME
300260 LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL
300266 SPASTIC PARAPLEGIA 16, X-LINKED; SPG16
300270 ADRENOMYODYSTROPHY
300271 MENTAL RETARDATION, X-LINKED 72; MRX72
300273 GOITER, MULTINODULAR 2; MNG2
300280 URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME
300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX
300310 AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2
300322 LESCH-NYHAN SYNDROME; LNS
300323 KELLEY-SEEGMILLER SYNDROME
300331 THROMBOCYTHEMIA, X-LINKED; THCYTX
300337 HYPOMELANOSIS OF ITO; HMI
300352 CREATINE DEFICIENCY SYNDROME, X-LINKED
300354 MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT
300360 MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE
300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA
300373 OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
300388 POLYMICROGYRIA, BILATERAL PERISYLVIAN; BPP
300400 SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
300423 MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH
300425 AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1
300431 ATKIN-FLAITZ SYNDROME
300436 MENTAL RETARDATION, X-LINKED 46; MRX46
300438 17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY
300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
300472 CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA
300486 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE
300488 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1
300489 SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3
300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS
300494 ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1
300495 AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2 MENTAL RETARDATION, X-LINKED, INCLUDED
300496 AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3
300497 ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2
300500 ALBINISM, OCULAR, TYPE I; OA1
300523 ALLAN-HERNDON-DUDLEY SYNDROME; AHDS
300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ
300539 NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD
300554 HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE
300558 MENTAL RETARDATION, X-LINKED 30; MRX30
300559 GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D
300571 HOLOPROSENCEPHALY, ECTRODACTYLY, AND BILATERAL CLEFT LIP/PALATE
300578 CHROMOSOME Xp11.3 DELETION SYNDROME
300580 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX
300600 ALAND ISLAND EYE DISEASE; AIED
300602 CLARK-BARAITSER SYNDROME
300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8
300612 BROOKS-WISNIEWSKI-BROWN SYNDROME
300614 DEAFNESS, X-LINKED 5; DFNX5
300619 CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION
300623 FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS
300624 FRAGILE X MENTAL RETARDATION SYNDROME
300650 ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD
300652 ANGIOMA SERPIGINOSUM, X-LINKED
300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
300659 MENTAL RETARDATION, X-LINKED 93; MRX93
300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD
300661 PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY
300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2
300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14
300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM
300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA EMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED
300700 ALBINISM-DEAFNESS SYNDROME; ADFN
300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5
300712 CRANIOFACIOSKELETAL SYNDROME
300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE
300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET
300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES
300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34
300751 ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA
300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA
300801 CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME
301000 WISKOTT-ALDRICH SYNDROME; WAS
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
301050 ALPORT SYNDROME, X-LINKED; ATS
301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E
301201 AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2
301220 PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR
301310 ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT
301410 NEURAL TUBE DEFECTS, X-LINKED SPINA BIFIDA, X-LINKED, INCLUDED
301500 FABRY DISEASE
301590 MICROPHTHALMIA, SYNDROMIC 4; MCOPS4
301700 ANOSMIA
301790 SPINOCEREBELLAR ATAXIA, X-LINKED 3
301800 ANUS, IMPERFORATE
301815 ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY
301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2
301835 ARTS SYNDROME; ARTS
301840 SPINOCEREBELLAR ATAXIA, X-LINKED 4
301845 BAZEX SYNDROME; BZX
301900 BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS
301940 BRACHYDACTYLY, MONONEN TYPE
301950 BRANCHIAL ARCH SYNDROME, X-LINKED
302000 BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE
302030 CALVARIAL HYPEROSTOSIS
302045 CARDIOMYOPATHY, DILATED, 3B; CMD3B
302060 BARTH SYNDROME; BTHS
302200 CATARACT, CONGENITAL, X-LINKED; CXN
302300 MICROPHTHALMIA, ISOLATED, WITH CATARACT 3; MCOPCT3
302350 NANCE-HORAN SYNDROME; NHS
302380 CATEL-MANZKE SYNDROME
302400 CENTRAL INCISORS, ABSENCE OF
302500 SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1
302600 SPINOCEREBELLAR ATAXIA, X-LINKED 2
302700 CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE
302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1
302801 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2
302802 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3
302803 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED
302905 CHARGE-LIKE SYNDROME, X-LINKED
302950 CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1
302960 CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2
303100 CHOROIDEREMIA; CHM
303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION
303350 MASA SYNDROME
303400 CLEFT PALATE, X-LINKED; CPX CLEFT PALATE WITH ANKYLOGLOSSIA, INCLUDED
303600 COFFIN-LOWRY SYNDROME; CLS
303650 COLONIC ATRESIA
303700 BLUE CONE MONOCHROMACY; BCM
303800 COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD
303900 COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP
304020 CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
304030 CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN
304050 AICARDI SYNDROME; AIC
304100 CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED
304110 CRANIOFRONTONASAL SYNDROME; CFNS
304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2
304150 OCCIPITAL HORN SYNDROME; OHS
304200 CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION
304300 CYANIDE, INABILITY TO SMELL
304340 DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES
304400 DEAFNESS, X-LINKED 2; DFNX2
304500 DEAFNESS, X-LINKED 1; DFNX1
304590 DEAFNESS, HIGH-FREQUENCY SENSORINEURAL, X-LINKED
304700 MOHR-TRANEBJAERG SYNDROME; MTS
304730 DERMOIDS OF CORNEA; CND
304790 IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX
304800 DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED
304900 DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED
305000 DYSKERATOSIS CONGENITA, X-LINKED; DKCX
305100 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED; XHED
305200 EHLERS-DANLOS SYNDROME, TYPE V
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2
305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2
305400 AARSKOG-SCOTT SYNDROME; AAS
305450 OPITZ-KAVEGGIA SYNDROME; OKS
305550 FINGERPRINT BODY MYOPATHY
305600 FOCAL DERMAL HYPOPLASIA; FDH
305620 FRONTOMETAPHYSEAL DYSPLASIA; FMD
305690 GENITOURINARY TRACT ANOMALIES
305700 SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1
305800 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1
306300 GRANULOMAS, CONGENITAL CEREBRAL
306400 GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGD
306500 GYNECOMASTIA, FAMILIAL
306700 HEMOPHILIA A; HEMA
306800 HEMOPHILIA A WITH VASCULAR ABNORMALITY
306900 HEMOPHILIA B; HEMB
306950 HERNIA, ANTERIOR DIAPHRAGMATIC
306955 HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1
306960 HHHH SYNDROME
306980 HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY
306990 HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE
307000 HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS
307030 HYPERGLYCEROLEMIA
307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2
307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3
307300 HYPOGONADISM, MALE
307500 HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES
307700 HYPOPARATHYROIDISM, X-LINKED; HYPX
307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR
307830 HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION
308050 CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS
308100 ICHTHYOSIS, X-LINKED; XLI
308200 ICHTHYOSIS AND MALE HYPOGONADISM RUD SYNDROME, INCLUDED
308205 IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME
308220 IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN
308230 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1
308240 LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1
308250 IMMUNOGLOBULIN M, LEVEL OF
308280 IMPACTED TEETH, MULTIPLE
308300 INCONTINENTIA PIGMENTI; IP
308350 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1
308500 IRIS HYPOPLASIA WITH GLAUCOMA; IHG
308600 JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY
308700 KALLMANN SYNDROME 1; KAL1
308750 KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA
308800 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX
308830 KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY
308850 LARYNGEAL ABDUCTOR PARALYSIS
308905 LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO
308930 LEIGH SYNDROME, X-LINKED
308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS
308950 LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT
308960 LEUKEMIA, ACUTE, ?X-LINKED
308990 PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS
309000 LOWE OCULOCEREBRORENAL SYNDROME; OCRL
309100 MACULAR DYSTROPHY, X-LINKED
309120 SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2
309200 MAJOR AFFECTIVE DISORDER 2; MAFD2
309300 MEGALOCORNEA; MGC1
309350 MELNICK-NEEDLES SYNDROME; MNS
309400 MENKES DISEASE
309480 MENTAL RETARDATION AND PSORIASIS
309500 RENPENNING SYNDROME 1; RENS1
309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS
309520 LUJAN-FRYNS SYNDROME
309530 MENTAL RETARDATION, X-LINKED 1; MRX1
309541 MENTAL RETARDATION, X-LINKED 3; MRX3
309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12
309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE
309555 MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES
309560 MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS
309580 MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1
309583 MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR
309585 WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS
309605 MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS
309610 PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS
309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD
309630 METACARPAL 4-5 FUSION; MF4
309640 MENTAL RETARDATION WITH SPASTIC PARAPLEGIA
309800 MICROPHTHALMIA, SYNDROMIC 1; MCOPS1
309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
309900 MUCOPOLYSACCHARIDOSIS TYPE II
309930 MUSCULAR DYSTROPHY, CARDIAC TYPE
309950 MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE
310000 MUSCULAR DYSTROPHY, MABRY TYPE
310095 MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL
310200 MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
310300 EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1
310350 MYELOLYMPHATIC INSUFFICIENCY
310370 MYOCLONIC EPILEPSY, PROGRESSIVE
310400 MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX
310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX
310460 MYOPIA 1, X-LINKED; MYP1
310465 N SYNDROME; NSX
310468 NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
310470 NEUROPATHY, HEREDITARY SENSORY, X-LINKED
310490 COWCHOCK SYNDROME
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
310600 NORRIE DISEASE; ND
310700 NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1
310800 NYSTAGMUS, MYOCLONIC
310900 OCCIPITAL HAIR, WHITE LOCK OF
310980 OMPHALOCELE, X-LINKED
311000 OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM
311050 OPTIC ATROPHY 2; OPA2
311070 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5
311100 OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME
311150 OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA
311200 OROFACIODIGITAL SYNDROME I; OFD1
311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO
311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1
311360 PREMATURE OVARIAN FAILURE 1; POF1
311400 PAINE SYNDROME
311450 PALLISTER W SYNDROME
311510 PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES
311900 TARP SYNDROME; TARPS
312000 PANHYPOPITUITARISM, X-LINKED; PHPX
312060 PROPERDIN DEFICIENCY, X-LINKED; CFPD
312080 PELIZAEUS-MERZBACHER DISEASE; PMD
312100 PSEUDOHERMAPHRODITISM, INCOMPLETE MALE, TYPE I
312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED
312170 PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD
312190 RADIAL APLASIA, X-LINKED
312200 RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER
312210 RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY
312300 ANDROGEN INSENSITIVITY, PARTIAL; PAIS
312500 RETICULOENDOTHELIOSIS, X-LINKED
312530 RETINAL DETACHMENT
312550 RETINAL DYSPLASIA, PRIMARY; PRD
312600 RETINITIS PIGMENTOSA 2; RP2
312612 RETINITIS PIGMENTOSA 6; RP6
312700 RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1
312750 RETT SYNDROME; RTT
312780 RUSSELL-SILVER SYNDROME, X-LINKED
312830 SCARF SYNDROME
312840 SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME
312860 SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION
312863 COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX
312870 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1
312910 SPASTIC PARAPARESIS AND DEAFNESS
312920 SPASTIC PARAPLEGIA 2, X-LINKED; SPG2
313200 SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
313350 SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT
313420 SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED
313490 TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS
313500 TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1
313850 THORACOABDOMINAL SYNDROME; THAS
313900 THROMBOCYTOPENIA 1; THC1
314000 THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE
314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT
314240 TOOTH SIZE
314250 DYSTONIA 3, TORSION, X-LINKED; DYT3
314300 TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR
314320 TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY
314360 ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET
314380 UNIQUE GREEN PHENOMENON
314390 VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX
314400 CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1
314500 VAN DEN BOSCH SYNDROME
314550 VESICOURETERAL REFLUX, X-LINKED; VURX
314560 VON WILLEBRAND DISEASE, X-LINKED FORM
314570 WIDOW'S PEAK SYNDROME
314580 WIEACKER SYNDROME
314600 WILDERVANCK SYNDROME
315000 ZONULAR CATARACT AND NYSTAGMUS
400043 DEAFNESS, Y-LINKED 1; DFNY1
415000 SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2
424500 GONADOBLASTOMA; GBY
425500 HAIRY EARS, Y-LINKED
475000 GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
500001 LEBER OPTIC ATROPHY AND DYSTONIA
500002 MITOCHONDRIAL MYOPATHY WITH DIABETES
500003 STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL
500007 CYCLIC VOMITING SYNDROME; CVS CYCLIC VOMITING SYNDROME WITH NEUROMUSCULAR DISEASE, INCLUDED
502500 ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL
515000 CHLORAMPHENICOL TOXICITY
520000 DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED
530000 KEARNS-SAYRE SYNDROME; KSS
535000 LEBER OPTIC ATROPHY
540000 MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS
545000 MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF
550500 MYOGLOBINURIA, RECURRENT
551000 MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM
551500 NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA
553000 ONCOCYTOMA
557000 PEARSON MARROW-PANCREAS SYNDROME
560000 RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA
580000 DEAFNESS, AMINOGLYCOSIDE-INDUCED
598500 WOLFRAM SYNDROME, MITOCHONDRIAL FORM
600000 SPONDYLOCAMPTODACTYLY
600001 PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD
600002 EIKEN SKELETAL DYSPLASIA
600057 EXSTROPHY OF BLADDER BLADDER EXSTROPHY AND EPISPADIAS COMPLEX, INCLUDED; BEEC, INCLUDED
600059 RETINITIS PIGMENTOSA 13; RP13
600060 DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2
600072 FATAL FAMILIAL INSOMNIA; FFI
600080 MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC
600081 VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B
600082 PROSTATIC HYPERPLASIA, BENIGN; BPH
600089 PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS
600092 CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME
600093 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES
600096 PUERTO RICAN INFANT HYPOTONIA SYNDROME
600101 DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A
600105 RETINITIS PIGMENTOSA 12; RP12
600110 STARGARDT DISEASE 3; STGD3
600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2
600117 DYSPHASIA, FAMILIAL DEVELOPMENTAL
600118 WARBURG MICRO SYNDROME 1; WARBM1
600121 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
600122 MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS
600131 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1
600132 RETINITIS PIGMENTOSA 14; RP14
600138 RETINITIS PIGMENTOSA 11; RP11
600142 CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL
600143 CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
600145 SACRAL DEFECT WITH ANTERIOR MENINGOCELE
600146 SPASTIC PARAPLEGIA 5B, AUTOSOMAL RECESSIVE; SPG5B
600155 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2
600156 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5
600159 PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES
600165 NANOPHTHALMOS 1; NNO1
600166 HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA
600171 GONADAL AGENESIS
600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE
600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS
600193 WAARDENBURG SYNDROME, TYPE 2B; WS2B
600195 VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM
600202 DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2
600204 EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS
600209 EXOSTOSES, MULTIPLE, TYPE III; EXT3
600223 SPINOCEREBELLAR ATAXIA 4; SCA4
600224 SPINOCEREBELLAR ATAXIA 5; SCA5
600231 PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB
600251 FACIAL CLEFTING, OBLIQUE, 1; OBLFC1
600252 LOWRY-MACLEAN SYNDROME
600256 HYDROCEPHALUS, AUTOSOMAL DOMINANT
600257 CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME
600263 HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
600268 APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS
600269 SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE
600273 POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS
600274 FRONTOTEMPORAL DEMENTIA; FTD
600302 FRYNS MACROCEPHALY
600309 ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3
600316 DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3
600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA
600329 OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY
600331 PARC SYNDROME
600332 RIPPLING MUSCLE DISEASE 1; RMD1
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA
600334 TIBIAL MUSCULAR DYSTROPHY, TARDIVE
600335 SUCCINIC ACIDEMIA
600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP
600348 BAND HETEROTOPIA OF BRAIN
600351 ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY
600360 APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE
600361 HEREDITARY MOTOR AND SENSORY NEUROPATHY V
600363 SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
600373 CODAS SYNDROME
600376 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED
600383 MESOMELIA-SYNOSTOSES SYNDROME
600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV
600399 PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL
600419 ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS
600430 BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR
600457 HYPERTRICHOSIS, ANTERIOR CERVICAL
600458 ADENOMYOSIS
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY
600461 HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES
600462 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1
600467 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4
600496 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
600501 ABCD SYNDROME; ABCDS
600510 GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
600512 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1
600513 EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1
600546 INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY
600559 HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS
600561 SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY
600593 CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA
600598 SETTING-SUN PHENOMENON, FAMILIAL BENIGN
600624 CONE-ROD DYSTROPHY 1; CORD1
600625 OROFACIAL CLEFT 11; OFC11
600627 HYPERTRYPTOPHANEMIA, FAMILIAL
600628 LOOSE ANAGEN HAIR SYNDROME
600630 UV-SENSITIVE SYNDROME 1; UVSS1
600631 ENURESIS, NOCTURNAL, 1; ENUR1
600634 PITUITARY ADENOMA, PROLACTIN-SECRETING
600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A
600643 CAROLI DISEASE, ISOLATED
600649 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE
600652 DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A
600666 POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3
600668 CHONDROCALCINOSIS 1; CCAL1
600669 EPILEPSY, IDIOPATHIC GENERALIZED; EIG
600670 VARICELLA, SEVERE RECURRENT
600674 MICROTIA-ANOTIA
600679 DERMOID CYSTS, FAMILIAL FRONTONASAL
600705 SATOYOSHI SYNDROME
600706 PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA
600721 D-2-@HYDROXYGLUTARIC ACIDURIA 1
600736 VELOFACIOSKELETAL SYNDROME
600737 INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE; IBM2
600740 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3
600757 OROFACIAL CLEFT 3; OFC3
600771 DWARFISM, FAMILIAL, WITH MUSCLE SPASMS
600775 LAMBDOID SYNOSTOSIS
600776 FRYNS MICROPHTHALMIA SYNDROME
600785 VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR; VDDR2B
600790 CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL
600791 DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4
600792 DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5
600794 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A
600795 FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3
600803 GALLBLADDER DISEASE 1; GBD1
600807 ASTHMA, SUSCEPTIBILITY TO
600808 ENURESIS, NOCTURNAL, 2; ENUR2
600852 RETINITIS PIGMENTOSA 17; RP17
600858 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6
600880 BUDD-CHIARI SYNDROME; BDCHS MEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED; MOVC, INCLUDED
600881 CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS
600882 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B
600884 CARDIOMYOPATHY, DILATED, 1B; CMD1B
600886 HYPERFERRITINEMIA-CATARACT SYNDROME
600901 FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM
600906 ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY
600907 ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS
600908 AGONADISM, 46,XY, WITH MENTAL RETARDATION, SHORT STATURE, RETARDED BONE AGE, AND MULTIPLE EXTRAGENITAL MALFORMATIONS
600919 CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED
600920 VAN DEN ENDE-GUPTA SYNDROME; VDEGS
600955 PROPROTEIN CONVERTASE 1/3 DEFICIENCY
600962 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK
600964 REFSUM DISEASE WITH INCREASED PIPECOLIC ACIDEMIA; RDPA
600965 DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6
600969 EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3 EPIPHYSEAL DYSPLASIA, MULTIPLE, 3, WITH MYOPATHY, INCLUDED
600972 ACHONDROGENESIS, TYPE IB; ACG1B
600974 DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
600975 GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B
600977 CONE-ROD DYSTROPHY 5; CORD5
600987 CARDIAC MALFORMATION, CLEFT LIP-PALATE, MICROCEPHALY AND DIGITAL ANOMALIES
600989 INFUNDIBULOPELVIC DYSGENESIS
600991 HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE
600994 DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5
600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2
600996 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2
601001 EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE
601003 BRODY MYOPATHY
601004 PORTAL VEIN, CAVERNOUS TRANSFORMATION OF
601005 TIMOTHY SYNDROME; TS
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM
601027 TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES
601039 ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN
601042 CHOREOATHETOSIS/SPASTICITY, EPISODIC; CSE
601067 USHER SYNDROME, TYPE ID; USH1D USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC, INCLUDED
601068 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1
601071 DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
601072 DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8; DFNB8
601075 APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION
601076 MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS
601085 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT; RESDAD
601086 LATERALITY DEFECTS, AUTOSOMAL DOMINANT
601088 CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION
601095 HARROD SYNDROME
601096 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC
601098 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C
601104 SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1
601110 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D
601127 FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION
601144 BRUGADA SYNDROME 1; BRGDA1
601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI
601154 CARDIOMYOPATHY, DILATED, 1E; CMD1E
601160 LISSENCEPHALY TYPE III AND BONE DYSPLASIA
601161 TRISOMY 18-LIKE SYNDROME
601162 SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT; SPG9
601163 DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION, AND LETHAL CONGENITAL HEART DISEASE
601170 MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS
601186 MICROPHTHALMIA, SYNDROMIC 9; MCOPS9
601187 GURRIERI SYNDROME
601200 PLEUROPULMONARY BLASTOMA; PPB
601202 CATARACT, ANTERIOR POLAR, 2; CTAA2
601214 NAXOS DISEASE
601216 PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA
601217 ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH
601222 CRANIOSYNOSTOSIS, PHILADELPHIA TYPE
601224 POTOCKI-SHAFFER SYNDROME
601228 POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1
601230 DERMATITIS HERPETIFORMIS, FAMILIAL
601238 CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY
601277 ICHTHYOSIS, LAMELLAR, 2; LI2
601286 CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL, AUTOSOMAL DOMINANT
601316 DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10
601317 DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11
601319 ODONTOMICRONYCHIAL DYSPLASIA
601321 NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS
601322 PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS
601331 RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD
601338 CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS
601341 ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC
601344 SPINAL DYSPLASIA, ANHALT TYPE
601345 ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE
601346 PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA, WITH OR WITHOUT TRACHEOESOPHAGEAL FISTULA
601347 MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY
601348 ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA
601349 MICROPHTHALMIA, SYNDROMIC 8; MCOPS8
601350 SHORT STATURE SYNDROME, BRUSSELS TYPE
601351 GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION
601352 MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE
601353 BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION
601355 MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS, AND HYPOSEGMENTED LUNGS
601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE
601357 BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH
601358 NICOLAIDES-BARAITSER SYNDROME; NCBRS
601360 AMELIA, AUTOSOMAL RECESSIVE
601363 WILMS TUMOR 4
601367 STROKE, ISCHEMIC
601370 HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS
601371 CATARACT, AGE-RELATED NUCLEAR
601372 CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT
601374 APROSENCEPHALY AND CEREBELLAR DYSGENESIS
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE
601376 CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY
601378 CRISPONI SYNDROME
601379 HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME
601382 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1
601386 DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
601389 CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION
601399 PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY
601410 DIABETES MELLITUS, TRANSIENT NEONATAL, 1
601412 DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7
601414 RETINITIS PIGMENTOSA 18; RP18
601419 MYOPATHY, MYOFIBRILLAR, 1; MFM1
601420 MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE
601427 ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS
601438 RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE
601449 DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM
601451 NEVO SYNDROME
601453 TRICHODENTAL DYSPLASIA
601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D
601457 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE
601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS
601466 PATENT DUCTUS VENOSUS; PDV
601471 FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1
601472 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D
601477 RIBBING DISEASE
601492 MUCOPOLYSACCHARIDOSIS TYPE IX
601493 CARDIOMYOPATHY, DILATED, 1C; CMD1C CARDIOMYOPATHY, DILATED, WITH LEFT VENTRICULAR NONCOMPACTION, INCLUDED
601494 CARDIOMYOPATHY, DILATED, 1D; CMD1D
601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2
601518 PROSTATE CANCER, HEREDITARY, 1; HPC1
601543 DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12
601544 DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A
601549 ALACRIMA, CONGENITAL
601552 ECTOPIA LENTIS, SPONTANEOUS FILTERING BLEBS, AND CRANIOFACIAL DYSMORPHISM
601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
601559 STUVE-WIEDEMANN SYNDROME
601560 MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE
601561 DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA
601583 WILMS TUMOR 5; WT5
601596 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C
601606 TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1
601608 SPASTIC PARAPLEGIA AND EVANS SYNDROME
601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT
601616 IRIS PIGMENT EPITHELIUM ANOMALIES
601626 LEUKEMIA, ACUTE MYELOID; AML
601631 IRIDOGONIODYSGENESIS, TYPE 1; IRID1
601650 PARAGANGLIOMAS 2; PGL2
601665 OBESITY LEANNESS, INCLUDED
601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD
601675 TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED
601678 BARTTER SYNDROME, ANTENATAL, TYPE 1
601680 ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B
601682 GLAUCOMA 1, OPEN ANGLE, C; GLC1C
601700 SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE
601701 ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA
601705 T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY
601706 YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME
601707 CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL SKIN AND GUT DEVELOPMENT
601708 SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL
601709 QUEBEC PLATELET DISORDER; QPD
601759 PREAXIAL HALLUCAL POLYDACTYLY
601764 SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1
601776 EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE
601777 CONE-ROD DYSTROPHY 6; CORD6
601780 CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6
601794 COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME
601803 PALLISTER-KILLIAN SYNDROME; PKS
601808 CHROMOSOME 18q DELETION SYNDROME
601809 SPONDYLOSPINAL THORACIC DYSOSTOSIS
601811 PREMATURE AGING SYNDROME, OKAMOTO TYPE
601812 PREMATURE AGING SYNDROME, PENTTINEN TYPE
601813 EXUDATIVE VITREORETINOPATHY 4; EVR4
601815 PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY
601816 BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1
601820 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2
601829 ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE
601846 VACUOLAR NEUROMYOPATHY
601847 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
601853 CEREBELLOTRIGEMINAL DERMAL DYSPLASIA
601859 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS
601868 DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
601884 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1 HIGH BONE MASS, INCLUDED; HBM, INCLUDED
601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2
601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES
601941 DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6
601942 DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10
601952 KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA
601954 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME
601977 THROMBOCYTHEMIA 2; THCYT2
601979 HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION
601992 FRIEDREICH ATAXIA 2
602014 HYPOMAGNESEMIA 1, INTESTINAL; HOMG1
602025 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9
602032 ECTODERMAL DYSPLASIA, 'PURE' HAIR-NAIL TYPE
602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA
602068 LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO
602071 BROAD TERMINAL PHALANGES, FAMILIAL
602078 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2
602079 TRIMETHYLAMINURIA; TMAU
602080 PAGET DISEASE OF BONE; PDB
602081 SPEECH-LANGUAGE DISORDER 1; SPCH1
602082 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2
602083 USHER SYNDROME, TYPE IF; USH1F
602085 POLYDACTYLY, POSTAXIAL, TYPE A2
602086 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3
602087 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4
602088 NEPHRONOPHTHISIS 2; NPHP2
602089 HEMANGIOMA, CAPILLARY INFANTILE
602092 DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18
602093 CONE DYSTROPHY 3; COD3
602096 ALZHEIMER DISEASE 5
602097 USHER SYNDROME, TYPE IE; USH1E
602099 AMYOTROPHIC LATERAL SCLEROSIS 5; ALS5
602107 NEUROPATHY, HEREDITARY THERMOSENSITIVE
602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE
602114 NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER DISEASE
602124 DYSTONIA 7, TORSION; DYT7
602134 TREMOR, HEREDITARY ESSENTIAL, 2; ETM2
602152 RHYNS SYNDROME
602196 PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES
602199 MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY
602200 VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY
602247 XANTHOMATOSIS, SUSCEPTIBILITY TO
602248 MALIGNANT ATROPHIC PAPULOSIS
602249 PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES
602271 SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL
602347 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3
602398 DESMOSTEROLOSIS
602418 WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME
602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4
602440 AMYOTROPHY, MONOMELIC
602450 SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION
602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES
602473 ENCEPHALOPATHY, ETHYLMALONIC; EE
602475 OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL
602477 FEBRILE SEIZURES, FAMILIAL, 2; FEB2
602481 MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2
602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3
602483 AURICULOCONDYLAR SYNDROME 1; ARCND1
602485 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3
602501 MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP
602522 BARTTER SYNDROME, TYPE 4A
602535 MARSHALL-SMITH SYNDROME; MRSHSS
602554 TORSION DYSTONIA WITH ONSET IN INFANCY
602557 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE
602579 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B
602588 BRANCHIOOTIC SYNDROME 1; BOS1
602613 SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL
602629 DYSTONIA 6, TORSION; DYT6
602668 MYOTONIC DYSTROPHY 2; DM2
602771 RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1
602849 MUENKE SYNDROME; MNKES
602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM ST. HELENA DYSPLASIA, INCLUDED
603034 ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD
603041 MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1
603116 CDAGS SYNDROME
603147 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C
603165 DERMATITIS, ATOPIC
603218 HUNTINGTON DISEASE-LIKE 1; HDL1
603221 MYOPIA 3, AUTOSOMAL DOMINANT; MYP3
603233 PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B
603284 CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING LOSS
603511 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E
603513 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1
603516 SPINOCEREBELLAR ATAXIA 10; SCA10
603543 LIMB-MAMMARY SYNDROME; LMS
603546 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2; SEMDJL2
603554 OMENN SYNDROME
603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8
603585 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F
603622 DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17 COCHLEOSACCULAR DEGENERATION, INCLUDED
603641 NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA
603671 ACROMELIC FRONTONASAL DYSOSTOSIS
603830 LONG QT SYNDROME 3; LQT3 LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED
603896 LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
603909 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A
604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1
604129 EPIDERMOLYSIS BULLOSA PRURIGINOSA
604168 CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY
604185 FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2
604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10
604218 ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB
604229 PETERS ANOMALY
604271 SHORT STATURE, IDIOPATHIC, AUTOSOMAL
604273 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATPAF2 TYPE
604278 RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION
604286 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E
604290 ACERULOPLASMINEMIA HYPOCERULOPLASMINEMIA, INCLUDED
604292 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3
604314 BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION
604320 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1
604326 SPINOCEREBELLAR ATAXIA 12; SCA12
604348 ADVANCED SLEEP-PHASE SYNDROME, FAMILIAL
604352 FEBRILE SEIZURES, FAMILIAL, 4; FEB4
604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11
604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3
604369 SIALURIA, FINNISH TYPE
604370 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1 BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED
604377 CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES
604387 NEPHRONOPHTHISIS 3; NPHP3
604393 LEBER CONGENITAL AMAUROSIS 4; LCA4 RETINITIS PIGMENTOSA, JUVENILE, AIPL1-RELATED, INCLUDED
604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2
604416 PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE
604432 SPINOCEREBELLAR ATAXIA 11; SCA11
604484 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE
604498 AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT
604563 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2
604571 BARE LYMPHOCYTE SYNDROME, TYPE I
604717 DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20
604801 MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B
604802 HUNTINGTON DISEASE-LIKE 3; HDL3
604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3
604805 SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12
604827 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7 MYOCLONIC EPILEPSY, JUVENILE, 2, INCLUDED; EJM2, INCLUDED
604841 STICKLER SYNDROME, TYPE II; STL2
604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA
604922 CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA
605013 MICROHYDRANENCEPHALY; MHAC
605021 MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME
605039 BOHRING-OPITZ SYNDROME; BOPS
605041 BROOKE-SPIEGLER SYNDROME; BRSS
605055 ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY
605229 SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14
605249 SEBASTIAN SYNDROME; SBS
605253 NEUROPATHY, CONGENITAL HYPOMYELINATING
605258 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2
605259 SPINOCEREBELLAR ATAXIA 13; SCA13
605274 MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE
605280 SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13
605285 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE
605309 MACROCEPHALY/AUTISM SYNDROME
605321 FRONTOOCULAR SYNDROME
605355 NEMALINE MYOPATHY 5; NEM5
605361 SPINOCEREBELLAR ATAXIA 14; SCA14
605373 PARAGANGLIOMAS 3; PGL3
605388 CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE
605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE
605419 SCHIZOPHRENIA 10; SCZD10
605432 RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA
605472 USHER SYNDROME, TYPE IIC; USH2C USHER SYNDROME, TYPE IIC, GPR98/PDZD7, DIGENIC, INCLUDED
605479 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
605543 PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4
605588 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1
605589 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2
605594 DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1
605627 CEREBROOCULONASAL SYNDROME
605670 LATE-ONSET RETINAL DEGENERATION; LORD
605685 CUTIS VERTICIS GYRATA, RETINITIS PIGMENTOSA, AND SENSORINEURAL DEAFNESS
605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED
605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2
605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12
605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2
605779 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7
605808 BIRDSHOT CHORIORETINOPATHY
605809 MYASTHENIA, FAMILIAL INFANTILE, 1
605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET
605820 NONAKA MYOPATHY; NM
605827 BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT
605850 DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
605899 GLYCINE ENCEPHALOPATHY; GCE
605909 PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6
606002 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1
606053 AUTISM, SUSCEPTIBILITY TO, 5; AUTS5
606054 PROPIONIC ACIDEMIA
606056 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B
606070 MYOPATHY, DISTAL, 2; MPD2
606071 HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C
606072 RIPPLING MUSCLE DISEASE; RMD RIPPLING MUSCLE DISEASE 2, INCLUDED; RMD2, INCLUDED
606155 FRYNS-AFTIMOS SYNDROME
606156 SENER SYNDROME
606159 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3
606170 GENITOPATELLAR SYNDROME; GTPTS
606176 DIABETES MELLITUS, PERMANENT NEONATAL; PNDM
606183 LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY
606217 ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2 ATRIOVENTRICULAR SEPTAL DEFECT, PARTIAL, WITH HETEROTAXY SYNDROME, INCLUDED
606232 CHROMOSOME 22q13.3 DELETION SYNDROME
606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM
606324 PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606353 PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ
606369 EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE
606407 HYPOTONIA-CYSTINURIA SYNDROME
606408 EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY
606438 HUNTINGTON DISEASE-LIKE 2; HDL2
606482 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB
606483 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA
606519 PHACE ASSOCIATION
606528 HOMOZYGOUS 11p15-p14 DELETION SYNDROME
606552 EPISODIC ATAXIA, TYPE 4; EA4
606554 EPISODIC ATAXIA, TYPE 3; EA3
606595 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F
606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5
606658 SPINOCEREBELLAR ATAXIA 15; SCA15 SPINOCEREBELLAR ATAXIA 16, FORMERLY; SCA16, FORMERLY
606664 GLYCINE N-METHYLTRANSFERASE DEFICIENCY
606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES
606693 KUFOR-RAKEB SYNDROME; KRS
606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM
606711 SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1
606712 SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2
606719 MELANOMA-PANCREATIC CANCER SYNDROME
606721 LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION
606762 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6
606764 GASTROINTESTINAL STROMAL TUMOR; GIST
606768 MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT
606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES
606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
606785 CRIGLER-NAJJAR SYNDROME, TYPE II
606798 BLEPHAROSPASM, BENIGN ESSENTIAL
606812 FUMARASE DEFICIENCY
606824 GLUCOSE/GALACTOSE MALABSORPTION; GGM
606835 DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
606840 PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB
606842 CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS
606843 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3
606851 CREE MENTAL RETARDATION SYNDROME
606854 POLYMICROGYRIA, BILATERAL FRONTOPARIETAL
606889 ALZHEIMER DISEASE 4
606895 SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH
606937 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5; SCAR5
606943 USHER SYNDROME, TYPE IG; USH1G
606966 NEPHRONOPHTHISIS 4; NPHP4
606995 SENIOR-LOKEN SYNDROME 3; SLSN3
606996 SENIOR-LOKEN SYNDROME 4; SLSN4
607004 BRACHYDACTYLY, TYPE A1, B
607014 HURLER SYNDROME
607060 PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8
607078 EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5
607080 46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY
607088 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3
607091 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D
607095 ANAUXETIC DYSPLASIA
607136 SPINOCEREBELLAR ATAXIA 17; SCA17
607152 SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19
607155 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
607174 MENINGIOMA, FAMILIAL
607200 THYROID DYSHORMONOGENESIS 6; TDH6
607208 DRAVET SYNDROME
607225 SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP
607236 HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION
607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7
607271 CASPASE 8 DEFICIENCY
607313 GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS; HGPPS OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL, AND SCOLIOSIS, INCLUDED
607317 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4
607323 DUANE-RADIAL RAY SYNDROME; DRRS
607326 SMITH-MCCORT DYSPLASIA; SMC
607330 LATHOSTEROLOSIS
607341 FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT
607346 SPINOCEREBELLAR ATAXIA 19; SCA19
607364 BARTTER SYNDROME, TYPE 3
607371 DYSTONIA, JUVENILE-ONSET
607373 AUTISM, SUSCEPTIBILITY TO, 8; AUTS8
607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2
607417 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2
607426 COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1
607432 LISSENCEPHALY 1; LIS1
607450 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8
607454 SPINOCEREBELLAR ATAXIA 21; SCA21
607458 SPINOCEREBELLAR ATAXIA 18; SCA18
607459 SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO
607475 BOTHNIA RETINAL DYSTROPHY
607483 THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2
607485 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED
607488 DYSTONIA 15, MYOCLONIC; DYT15
607498 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3
607499 BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1
607501 MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4
607508 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5
607516 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6
607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
607552 MINICORE MYOPATHY, ANTENATAL ONSET, WITH ARTHROGRYPOSIS
607554 ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
607565 SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION
607569 MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT
607578 BREATH-HOLDING SPELLS
607584 SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24
607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1
607595 BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE
607596 PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A
607597 MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES
607598 LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2
607602 ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS
607616 NIEMANN-PICK DISEASE, TYPE B NIEMANN-PICK DISEASE, TYPE E, INCLUDED
607624 GRISCELLI SYNDROME, TYPE 2; GS2
607625 NIEMANN-PICK DISEASE, TYPE C2
607626 ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS
607628 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8, INCLUDED; EJM8, INCLUDED
607631 EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1
607634 OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1
607636 VAN BUCHEM DISEASE, TYPE 2
607641 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B
607655 SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS
607665 TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU ACUTE TUBULOINTERSTITIAL NEPHRITIS, INCLUDED; ATIN, INCLUDED
607671 DYSTONIA 13, TORSION; DYT13
607674 CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY
607677 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I
607678 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D
607681 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2
607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6, INCLUDED
607684 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E
607685 HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES
607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE
607731 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H
607734 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F
607736 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J
607745 SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3
607765 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1
607778 ACROCAPITOFEMORAL DYSPLASIA; ACFD
607791 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID
607801 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C
607812 CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD
607822 ALZHEIMER DISEASE 3
607823 HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS
607829 MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2
607831 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K
607850 OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3
607855 MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
607859 ANGIOMA, TUFTED
607872 CHROMOSOME 1p36 DELETION SYNDROME
607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2
607932 MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
607944 SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI
608013 GAUCHER DISEASE, PERINATAL LETHAL
608022 DIAPHANOSPONDYLODYSOSTOSIS
608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3
608028 THAI SYMPHALANGISM SYNDROME
608029 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6
608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, 3, SUSCEPTIBILITY TO; IIAE3
608049 AUTISM, SUSCEPTIBILITY TO, 3; AUTS3
608051 MACULAR DYSTROPHY, RETINAL, 2; MCDR2
608088 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX
608091 JOUBERT SYNDROME 2; JBTS2
608093 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J
608096 EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2
608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D
608105 EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC
608106 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5
608115 OVARIAN HYPERSTIMULATION SYNDROME
608118 ZINC IN BREAST MILK, REDUCED ZINC DEFICIENCY, NEONATAL, DUE TO LOW BREAST MILK ZINC, INCLUDED
608154 LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES
608156 NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS
608180 SYNPOLYDACTYLY 2; SPD2
608184 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4
608189 TROPICAL CALCIFIC PANCREATITIS
608217 SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3
608219 DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION
608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2
608236 SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT
608244 OTOSCLEROSIS 3; OTSC3
608257 MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT
608264 DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40
608265 DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS
608320 CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1
608323 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC
608328 WEILL-MARCHESANI SYNDROME 2; WMS2
608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA
608345 NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3
608358 MYOPATHY, MYOSIN STORAGE
608361 SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE
608363 CHROMOSOME 22q11.2 DUPLICATION SYNDROME
608367 MYOPIA 17, AUTOSOMAL DOMINANT; MYP17
608372 DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49
608390 MYOTONIA, POTASSIUM-AGGRAVATED
608393 MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6
608404 PLATELET GLYCOPROTEIN IV DEFICIENCY
608406 VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY
608423 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3
608454 KNOBLOCH SYNDROME 2; KNO2
608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
608474 MYOPIA 5, AUTOSOMAL DOMINANT; MYP5
608540 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K
608545 LARSEN-LIKE SYNDROME
608567 SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE; SSS1
608571 ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY
608572 BURN-MCKEOWN SYNDROME
608583 ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1
608591 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G; CMT2G
608594 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1
608600 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1
608611 RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY
608612 MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB
608622 HYPERTENSION, DIASTOLIC, RESISTANCE TO
608624 MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA
608629 JOUBERT SYNDROME 3; JBTS3
608631 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2
608634 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B
608636 CHROMOSOME 15q11-q13 DUPLICATION SYNDROME
608638 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1
608641 DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
608643 AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
608654 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5
608673 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L
608687 SPINOCEREBELLAR ATAXIA 20; SCA20
608688 AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY
608703 SPINOCEREBELLAR ATAXIA 25; SCA25
608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD
608716 MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA
608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED
608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY
608763 EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE
608768 SPINOCEREBELLAR ATAXIA 8; SCA8
608782 PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD
608799 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E
608800 SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT
608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2
608807 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J
608809 LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH
608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2
608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL
608840 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6
608864 OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6
608890 WAARDENBURG SYNDROME, TYPE 2D; WS2D
608902 DRUG METABOLISM, POOR, CYP2D6-RELATED DRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED
608930 MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL
608931 MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY
608957 CD8 DEFICIENCY, FAMILIAL
608984 ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1
608995 DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8
609008 MARFANOID HABITUS WITH SITUS INVERSUS
609015 TRIFUNCTIONAL PROTEIN DEFICIENCY
609021 PERIPHERAL CONE DYSTROPHY
609029 EMANUEL SYNDROME
609033 POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1
609037 MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE
609039 NARCOLEPSY 3; NRCLP3
609040 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9
609041 SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27
609048 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3
609049 PIERSON SYNDROME
609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4
609055 CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9
609056 AMISH INFANTILE EPILEPSY SYNDROME
609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
609115 LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G
609129 AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1
609136 PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH
609152 HYPERTHYROIDISM, NONAUTOIMMUNE
609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD
609162 CZECH DYSPLASIA
609166 BRANCHIOGENIC-DEAFNESS SYNDROME
609192 LOEYS-DIETZ SYNDROME, TYPE 1A; LDS1A
609195 SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26
609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3
609200 MYOPATHY, MYOFIBRILLAR, 3; MFM3
609220 BRUCK SYNDROME 2; BRKS2
609222 DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT; ADDWOC
609223 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE
609227 GRISCELLI SYNDROME, TYPE 3; GS3
609241 SCHINDLER DISEASE, TYPE I
609242 KANZAKI DISEASE
609253 FEBRILE SEIZURES, FAMILIAL, 6; FEB6
609254 SENIOR-LOKEN SYNDROME 5; SLSN5
609255 FEBRILE SEIZURES, FAMILIAL, 5; FEB5
609260 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2
609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7
609283 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2; PEOA2
609284 NEMALINE MYOPATHY 1; NEM1 CAP MYOPATHY, TPM3-RELATED, INCLUDED
609285 NEMALINE MYOPATHY 4; NEM4 CAP MYOPATHY, TPM2-RELATED, INCLUDED
609286 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3; PEOA3
609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3
609306 SPINOCEREBELLAR ATAXIA 26; SCA26
609307 SPINOCEREBELLAR ATAXIA 27; SCA27
609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1
609311 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H
609322 RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1
609324 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA
609325 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES
609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28
609384 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C
609425 CHROMOSOME 3q29 DELETION SYNDROME
609428 TUKEL SYNDROME
609432 SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL BLOCK
609439 DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48
609441 CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES
609446 GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD
609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4
609454 SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2
609456 MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE
609460 GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME
609500 MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET
609524 MYOPATHY, MYOFIBRILLAR, 5; MFM5
609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME
609533 DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23
609541 SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN
609560 MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2
609566 PARIETAL FORAMINA 3; PFM3
609583 JOUBERT SYNDROME 4; JBTS4
609597 PARIETAL FORAMINA 2; PFM2
609616 SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE CALCIFICATIONS, AND DEAFNESS
609625 CHROMOSOME 10q26 DELETION SYNDROME
609634 MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3
609636 ALZHEIMER DISEASE 10
609637 HOLOPROSENCEPHALY 5; HPE5
609638 EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC
609646 DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42
609647 DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46
609649 TRICHILEMMAL CYST 1; TRICY1
609654 SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS
609655 TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS
609727 SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29
609796 PEELING SKIN SYNDROME, ACRAL TYPE
609800 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4
609808 HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS
609814 COMPLEMENT FACTOR H DEFICIENCY; CFHD
609820 ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3
609821 BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8
609823 DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
609924 AMINOACYLASE 1 DEFICIENCY
609941 DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51
609943 HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES
609944 ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA
609968 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5
609975 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4
610003 CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
610006 2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
610021 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7
610031 POLYMICROGYRIA, ASYMMETRIC
610090 PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY
610099 MYOPATHY, DISTAL, 3; MPD3
610100 GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT
610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
610131 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4; PEOA4
610140 HEART-HAND SYNDROME, SLOVENIAN TYPE
610143 DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
610153 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
610154 DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
610156 MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS
610168 LOEYS-DIETZ SYNDROME, TYPE 1B; LDS1B
610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2
610188 JOUBERT SYNDROME 5; JBTS5
610189 SENIOR-LOKEN SYNDROME 6; SLSN6
610193 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10
610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5
610202 CATARACT, PULVERULENT, JUVENILE-ONSET CATARACT, CONGENITAL, CERULEAN TYPE, 4, INCLUDED; CCA4, INCLUDED
610204 PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5
610208 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10
610209 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11
610217 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B
610244 SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33
610246 SPINOCEREBELLAR ATAXIA 28; SCA28
610248 DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65
610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
610253 KLEEFSTRA SYNDROME
610256 APHAKIA, CONGENITAL PRIMARY
610279 PACHYGYRIA, FRONTOTEMPORAL
610282 RETINITIS PIGMENTOSA 35; RP35
610283 CONE-ROD DYSTROPHY 10; CORD10
610293 GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY
610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA
610338 RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL
610353 EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4
610357 SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30
610370 DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4
610377 MEVALONIC ACIDURIA MEVALONATE KINASE DEFICIENCY, INCLUDED
610419 DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68
610420 PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1
610422 ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2
610442 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE
610443 MENTAL RETARDATION, AUTOSOMAL DOMINANT 17; MRD17
610445 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
610448 CHILBLAIN LUPUS 1; CHBL1
610455 TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC
610474 CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610475 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610476 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610489 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
610498 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
610505 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
610532 LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5
610535 GLAUCOMA 1, OPEN ANGLE, M; GLC1M
610536 MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM
610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1
610543 CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL
610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY
610634 CATARACT, POSTERIOR POLAR, 5; CTPP5
610651 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB
610655 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS
610682 OSTEOGENESIS IMPERFECTA, TYPE VII
610688 JOUBERT SYNDROME 6; JBTS6
610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA
610708 OPTIC ATROPHY 5; OPA5
610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3
610738 NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3
610755 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4
610765 ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE
610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M
610797 EPIPHYSEAL DYSPLASIA, BAUMANN TYPE
610798 IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN
610828 HOLOPROSENCEPHALY 7; HPE7
610829 HOLOPROSENCEPHALY 9; HPE9
610840 MITRAL VALVE PROLAPSE, MYXOMATOUS 3; MMVP3
610852 CILIARY DYSKINESIA, PRIMARY, 6; CILD6
610883 POTOCKI-LUPSKI SYNDROME; PTLS
610910 PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED
610913 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2
610915 OSTEOGENESIS IMPERFECTA, TYPE VIII
610921 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3
610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7
610954 PITT-HOPKINS SYNDROME; PTHS
610967 OSTEOGENESIS IMPERFECTA, TYPE V
610968 OSTEOGENESIS IMPERFECTA, TYPE XI; OI11
610978 CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS
610984 COMPLEMENT FACTOR I DEFICIENCY; CFID
610992 PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY
611022 DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24
611031 EPISODIC KINESIGENIC DYSKINESIA 2; EKD2
611038 MICROPHTHALMIA, ISOLATED 3; MCOP3
611040 MICROPHTHALMIA, ISOLATED 5; MCOP5
611067 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4
611102 DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
611126 ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF
611131 RETINITIS PIGMENTOSA 37; RP37
611147 PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2
611225 SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18
611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32
611263 ASPHYXIATING THORACIC DYSTROPHY 2; ATD2
611284 DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD MUSICIAN'S DYSTONIA, INCLUDED
611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2
611307 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L
611364 MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4
611376 MUNGAN SYNDROME; MGS
611377 BRACHYDACTYLY, TYPE B2; BDB2
611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3
611426 TENTED EYEBROWS
611431 LEGIUS SYNDROME
611489 CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY
611528 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12
611561 MECKEL SYNDROME, TYPE 5; MKS5
611571 OTOSCLEROSIS 4; OTSC4
611572 OTOSCLEROSIS 7; OTSC7
611584 WAARDENBURG SYNDROME, TYPE 2E; WS2E
611588 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4
611597 CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1
611603 LISSENCEPHALY 3; LIS3
611615 CARDIOMYOPATHY, DILATED, 1X; CMD1X
611630 EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3
611631 EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4
611634 FEBRILE SEIZURES, FAMILIAL, 9; FEB9
611637 PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1
611638 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5
611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA
611702 SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE
611705 MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY
611717 SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH
611719 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5
611721 COMBINED SAPOSIN DEFICIENCY
611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY
611726 EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3
611808 TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS; ETINPH
611812 46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL
611816 TEMPLE-BARAITSER SYNDROME
611867 CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL
611881 GLYCOGEN STORAGE DISEASE XII; GSD12
611884 CILIARY DYSKINESIA, PRIMARY, 7; CILD7
611907 EPISODIC ATAXIA, TYPE 7; EA7
611926 IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS
611929 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III
611936 CHROMOSOME 3q29 DUPLICATION SYNDROME
611944 LYMPHEDEMA, HEREDITARY, IB
611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37
611961 STEVENSON-CAREY SYNDROME
611962 HUNTER-MACDONALD SYNDROME
612001 CHROMOSOME 15q13.3 DELETION SYNDROME
612067 DYSTONIA 16; DYT16
612073 MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONIC ACIDURIA); MTDPS5
612079 ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME
612089 HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM
612095 RETINITIS PIGMENTOSA 41; RP41
612096 OTOSCLEROSIS 8; OTSC8
612097 DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS
612098 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11
612119 TREHALASE DEFICIENCY
612124 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12
612132 ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT
612138 EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA
612164 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4
612198 DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA
612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC
612201 ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6
612227 DIABETES MELLITUS, KETOSIS-PRONE; KPD
612229 COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3
612233 LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4
612285 JOUBERT SYNDROME 9; JBTS9 JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED
612286 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1
612287 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2
612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE
612304 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4
612319 SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35
612335 SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38
612336 THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5
612350 SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE
612356 HEPARIN COFACTOR II DEFICIENCY
612379 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q
612394 BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS
612406 DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17
612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B
612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6
612447 SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION
612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C
612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP
612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME
612513 CHROMOSOME 2p16.1-p15 DELETION SYNDROME
612530 CHROMOSOME 1q41-q42 DELETION SYNDROME
612539 SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
612540 MYOPATHY, CONGENITAL, COMPTON-NORTH
612541 NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4 DURSUN SYNDROME, INCLUDED
612555 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2 BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED
612582 CHROMOSOME 6pter-p24 DELETION SYNDROME
612626 CHROMOSOME 15q26-qter DELETION SYNDROME
612651 ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO
612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC
612713 KAHRIZI SYNDROME; KHRZ
612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS
612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY
612717 MYOPIA 15, AUTOSOMAL DOMINANT; MYP15
612726 HARDIKAR SYNDROME
612731 FACIOCARDIOMELIC SYNDROME
612736 GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY
612740 PORPHYRIA, ACUTE HEPATIC
612776 HYPOGLOSSIA WITH SITUS INVERSUS HYPOGLOSSIA, ISOLATED, INCLUDED
612780 SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES
612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1
612783 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2
612813 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE
612840 LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3
612843 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD
612847 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE
612913 OROFACIODIGITAL SYNDROME XI; OFD11
612917 GIACHETI SYNDROME
612932 GLYCOGEN STORAGE DISEASE XIII; GSD13
612933 GLYCOGEN STORAGE DISEASE XI; GSD11
612934 GLYCOGEN STORAGE DISEASE XIV; GSD14
612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50
612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY DEATH; GDFD
612940 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B
612946 HADZISELIMOVIC SYNDROME
612947 MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, MENTAL RETARDATION, AND DYSMORPHIC FEATURES
612949 HYPOMYELINATION, GLOBAL CEREBRAL
612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY
612954 MYOPATHY, MYOFIBRILLAR 6, MFM6
612998 EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4
612999 EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5
613005 SANTOS SYNDROME
613011 LYMPHOPROLIFERATIVE SYNDROME, EBV-ASSOCIATED, AUTOSOMAL, 1
613021 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2
613026 CHROMOSOME 19q13.11 DELETION SYNDROME
613027 GLYCOGEN STORAGE DISEASE IXc; GSD9C
613038 PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1
613068 NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY
613070 LIVER FAILURE, INFANTILE, TRANSIENT; LFIT
613071 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3
613090 BARTTER SYNDROME, TYPE 4B
613093 CONE DYSTROPHY 4; COD4 ACHROMATOPSIA 5, INCLUDED; ACHM5, INCLUDED
613094 MICROPHTHALMIA, ISOLATED 4; MCOP4
613096 SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36
613097 TOOTH AGENESIS, SELECTIVE, 6; STHAG6
613105 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2
613115 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B
613124 HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES
613135 PARKINSONISM-DYSTONIA, INFANTILE; PKDYS
613161 BETA-UREIDOPROPIONASE DEFICIENCY
613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45
613163 GABA-TRANSAMINASE DEFICIENCY
613174 CHROMOSOME 5p13 DUPLICATION SYNDROME
613179 PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA
613217 DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5
613225 FACTOR XIII, A SUBUNIT, DEFICIENCY OF
613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3
613229 TRICHOTILLOMANIA; TTM
613235 FACTOR XIII, B SUBUNIT, DEFICIENCY OF
613254 TUBEROUS SCLEROSIS 2; TSC2 TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED
613265 WAARDENBURG SYNDROME, TYPE 4B; WS4B
613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C
613319 MIYOSHI MUSCULAR DYSTROPHY 3; MMD3
613320 CHONDRODYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE
613327 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4
613328 ROIFMAN-CHITAYAT SYNDROME
613329 PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY
613339 EPILEPSY, HOT WATER, 1; HWE1
613341 LEBER CONGENITAL AMAUROSIS 14; LCA14 RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED
613345 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2
613353 MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN
613355 CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME
613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C
613382 BRACHYDACTYLY, TYPE E2; BDE2
613391 DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84
613406 CHROMOSOME 15q24 DELETION SYNDROME CHROMOSOME 15q24 DUPLICATION SYNDROME, INCLUDED
613424 CARDIOMYOPATHY, DILATED, 1R; CMD1R LEFT VENTRICULAR NONCOMPACTION 4, INCLUDED; LVNC4, INCLUDED
613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
613675 CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB
613697 CARDIOMYOPATHY, DILATED, 1V; CMD1V
613703 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6
613731 RETINITIS PIGMENTOSA 4; RP4
613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY
* quick link - http://q.sanger.ac.uk/w1n11z9l